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ABSTRACT 
Escherichia coli RecA is a versatile protein that is involved in homologous 
recombination, and coordination of both the DNA damage response and translesion 
synthesis.  Single-stranded DNA (ssDNA) that is generated at the site of double-stranded 
breaks serves as a signal to activate RecA.  This allows RecA to form a long helical 
filament on the ssDNA, which is required in recombination, hydrolysis of ATP, and 
mediating the self-cleavage of some ser-lys dyad proteins such as the LexA repressor. 
In this thesis, the formation of the RecA/LexA complex did not require 
preactivation by ssDNA, instead a volume excluding agent in the presence of LexA was 
able to stimulate its formation.  These preliminary results led to a hypothesis that the 
formation of the RecA/LexA complex is a thermodynamic process that involves three 
steps: (1) a change in RecA’s conformation towards the active form, (2) a change in 
LexA’s conformation towards the cleavable form (i.e. burial of the ser-lys dyad catalytic 
residues), and (3) the binding between the active form of RecA and the cleavable form of 
LexA.  Evidence for this model was shown by the ability of either NaCl, LexA K156A, 
an ATP substrate, or a volume excluding agent to enhance the stability of the RecA/LexA 
complex, which was detected by both the ATPase and coprotease assays.  Hyper-active 
RecA mutants, isolated form the yeast two-hybrid screen, were also tested, however they 
did not enhance the stability of the complex.  Additionally, RecA’s binding preference 
for the monomer or dimer form of LexA was examined, since it is unknown which 
species of LexA is able to enhance the stability of the complex.  To generate the 
monomer form of LexA, single point mutations were introduced at the dimer interface of 
the protein such that its dimerization was disrupted by charge-charge repulsions.  Based 
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on the inhibition assay, RecA was found to bind preferentially to dimer form and not the 
monomer form of LexA, possible reasons for these results are discussed. 
 iv
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1. INTRODUCTION 
Escherichia coli RecA protein is a general recombinase that is involved in the 
repair of double-stranded DNA (dsDNA) breaks caused by DNA-damaging agents and 
natural processing events (Friedberg et al., 1995).  RecA also has a coprotease activity 
that is essential  to coordinate the “SOS” regulon, a series of ~40 unlinked genes that are 
required for post-replication repair (Courcelle et al., 2001; Friedberg et al., 1995).  The 
single-stranded DNA (ssDNA), generated at ends of the double-strand breaks, serves as a 
signal to activate RecA’s coprotease activity (Kowalczykowski et al., 1994).  In turn, the 
LexA repressor becomes a target for RecA-mediated cleavage, which leads to the 
transcriptional derepression of the SOS regulon (Walker, 1985). 
RecA’s coprotease activity is believed to facilitate the self-cleavage of the LexA 
repressor by providing a hydrophobic pocket (Lin and Little, 1989), which reduces the 
energetic cost in the burial and deprotonation of the ε-amino group of K156 in LexA 
(Luo et al., 2001).  Alternatively, the LexA repressor can undergo self-cleavage in the 
absence of RecA at neutral pH in vitro, but its rate of self-cleavage is dramatically 
reduced by 10,000-fold (Roland et al., 1992).  Under the latter conditions, LexA exists in 
a non-cleavable conformation where the ε-amino group of the K156 residue is exposed to 
the aqueous environment (Figure 2.3). 
In vitro, the inactive form of RecA is able to self-polymerize at high protein 
concentrations, or at low protein concentrations in the presence of Mg2+ ions (Brenner et 
al., 1988).  This occurs through the interaction between its N-terminal tail domain and its 
head (central) domain, which generates a right-handed helical filament (Story et al., 
1992; Takahashi et al., 1996).  Based on the small-angle neutron scattering studies, the 
self-polymer has a physical characteristic of 6.4 subunits per turn with a compressed 
helical pitch of <70 Å (DiCapua et al., 1990b).  The active form of RecA is correlated to 
its enzymatic activities (ATPase, coprotease, and recombinase), which requires the 
binding of ATP, excess Mg2+ ions, and ssDNA (Kowalczykowski et al., 1994; Roman 
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and Kowalczykowski, 1986).  Based on the electron microscopy structures and small-
angel neutron scattering studies, all three enzymatic activities have a common physical 
characteristic of 6.2 subunits per turn with an extended helical pitch of >95 Å (DiCapua 
et al., 1992; DiCapua et al., 1990a; Yu and Egelman, 1992).  RecA’s active form can be 
deactivated upon hydrolysis of ATP to ADP, which compresses the helical pitch to ~80 Å 
and increases the number of subunits per turn to ~6.4 (DiCapua et al., 1990b; Story et al., 
1992; Yu et al., 2001).  In general, the RecA filament exists in two conformations, a 
compressed or an extended helical pitch that is correlated to its inactive or active states 
respectively (DiCapua et al., 1990b). 
As mentioned above, the extended helical pitch of the RecA filament is correlated 
to its active form (i.e. its ATPase and coprotease activity), no matter how the activation is 
brought about (DiCapua et al., 1992; DiCapua et al., 1990a).  This relationship, the level 
of RecA’s ATPase and coprotease activity, was applied to this study in order to detect the 
formation of the RecA/LexA complex in vitro.  It was found that RecA’s enzymatic 
activities were stimulated with increasing concentrations of a volume-excluding agent, 
polyethylene glycol (PEG) in the presence of wild-type LexA, such that preactivation by 
ssDNA was not required.  Therefore, it is proposed that the formation of a RecA/LexA 
complex is a thermodynamic process that can be broken down into three steps: (1) 
activation of RecA (the active form), (2) stabilization of LexA’s cleavable conformation 
(the cleavable form), and (3) binding between the active form of RecA and the cleavable 
form of LexA.  To provide evidence for this model, the stability of the RecA/LexA 
complex was enhanced by decreasing the energy barrier that was associated at each step 
in the thermodynamic process. 
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2. REVIEW OF LITERATURE 
2.1. RecA Protein 
Escherichia coli RecA protein is a multifunctional protein that is essential for 
three different biological functions: (1) general recombination, (2) coordination of 
unlinked DNA repair genes in response to DNA damage, and (3) coordination of 
translesion synthesis (Bianco and Kowalczykowski, 2001).  Thus, RecA possesses a 
number of different enzymatic activities, such as homologous pairing and exchange of 
DNA, ATP- and DNA-dependent coproteolytic processing of effector proteins, and 
interacting with mutagenic protein factors that  are involved in translesion synthesis 
(Kowalczykowski et al., 1994). 
Given RecA’s essential role in maintaining the genomic integrity and consequent 
survival of the cell in response to DNA damaging agents, it is not surprising that the 
protein is conserved among a wide range of prokaryotic organisms.  Additionally, RecA 
has a structural homology with other recombinases found in eukaryotic and archaeal 
organisms (Kowalczykowski and Eggleston, 1994).  The conserved structure of RecA in 
various organisms suggests that all of the recombinases have evolved from a common 
ancestor (Kowalczykowski and Eggleston, 1994). 
2.2. Overview of RecA’s Biological Functions 
RecA was first discovered by Clark and Margulies (1965) when screening 
bacterial cells that were defective in recombination.  Later on, the protein was found to be 
essential for all pathways associated with homologous recombination, such as prophage 
production and DNA damage response (SOS induction) with the exception of recET-
mediated plasmid recombination (Bianco et al., 1998).  For example, mutations in both 
recA and uvrA genes made the cells defective in specific types of DNA repair upon 
exposure to DNA damaging agents, such as the repair of DNA-cross links, double-
stranded breaks, and bypass of modified DNA bases (Kowalczykowski et al., 1994). 
2.2.1. SOS Induction 
The RecA protein and the LexA repressor play a central role in coordinating 
various unlinked DNA-repair genes in E. coli, which is collectively referred to as the 
SOS response (Figure 2.1) (Witkin, 1991).  Activation of the SOS response involves the 
generation of ssDNA at the site of dsDNA breaks upon exposure to DNA damaging 
agents.  This serves as a signal to activate RecA’s coprotease activity, which is 
responsible for mediating the cleavage of the LexA repressor (Horrii et al., 1981; Little et 
al., 1980).  The self-proteolytic cleavage of the LexA repressor occurs at the A84-G85 
peptide, which separates its DNA binding domain from its dimerization domain (Slilaty 
and Little, 1987), and in turn leads to the transcriptional derepression of ~40 unlinked 
genes that belong to the SOS regulon (Courcelle et al., 2001; Walker, 1985).  RecA’s 
coprotease activity also targets other LexA homologs such as the lytic repressor protein 
(either λ, φ80, 434, or P22) of lambdoid bacteriophages (Eguchi et al., 1988; Roberts et 
al., 1978; Sauer et al., 1982), and a mutagenic factor (UmuD) that is involved in the 
error-prone DNA replicative bypass machinery (Rajagopalan et al., 1992; Shinagawa et 
al., 1988). 
 
Figure 2.1. A cartoon diagram depicting the activation of the SOS response. 
Upon exposure to DNA damaging agents, (a) the ends of the damaged dsDNA 
breaks are processed into 3’-OH ssDNA tails.  (b) RecA’s coprotease activity is 
activated when the protein binds to the 3’-OH ssDNA tails to form an extended 
RecA nucleofilament.  (c) The nucleofilament binds to the LexA repressor to form a 
RecA/LexA complex, which (d) facilitates the self-cleavage of LexA, and 
consequently leads to the transcriptional derepression of the SOS genes (SOS 
induction).  (The figure was modified from Bianco and Kowalczykowski, 1998). 
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Activation of the SOS response is also implicated in the epidemiology of Shiga 
toxin producing E. coli (STEC).  Shiga toxins are encoded in the bacteriophage genes that 
are integrated in the host E. coli chromosome (Kuzminov, 1999) and they are the main 
cause of food borne illnesses in the developed countries (Haque et al., 2003).  The release 
of Shiga toxins into the gut can increase the risk for developing hemolytic anemia, 
thrombocytopenia, acute renal failure, and complications of the central nervous system 
(http://www.cdc.gov/epo/dphsi/casedef/hemolyticcurrent.htm).  Presently, there is no 
conventional therapy for treating severe STEC infections, because certain antibiotics are 
known to increase the severity of the infection (Schuller et al., 2005; Wong et al., 2000).  
Antibiotics such as the quinolones can cause DNA damage in STEC, and in turn can lead 
to the activation of both the SOS response pathway and the lytic pathway of lambdoid 
bacteriophage that is integrated in the bacterial chromosome (Kimmitt et al., 2000; 
Kuzminov, 1999; Quillardet and Hofnung, 1993).  These two pathways are consequently 
activated by ssDNA when the integrity of the genome is compromised.  The ssDNA 
serves as a signal to activate RecA-mediated cleavage of the CI phage repressor (Kim and 
Little, 1993), a LexA homolog, and in turn lead to the transcriptional derepression of 
phage particles (e.g. Shiga toxins) and host bacterial cell lysis (Kuzminov, 1999; 
Oppenheim et al., 2005).  Thus, drugs that target the RecA/CI phage repressor complex 
may be beneficial in treating severe STEC diseases. 
2.2.2. RecA-mediated Cleavage of Wild-type LexA 
The role of the activated RecA nucleofilament is believed to provide a 
hydrophobic pocket in the burial and deprotonation of the ε-amino group of the K156 
residue in LexA (Lin and Little, 1989; Luo et al., 2001).  This shifts LexA’s 
conformation towards the cleavable form, thereby increasing its rate of self-cleavage by 
10,000-fold at neutral pH as predicted by the conformation-equilibrium model (Figure 
2.2) (Roland et al., 1992).  The energy barrier, required to shift LexA’s conformation 
from the non-cleavable form to the cleavable form (Figure 2.3), is believed to maintain 
LexA’s self-cleavage reaction in check in the absence of RecA (Luo et al., 2001).  
Additionally, RecA-mediated cleavage for all other LexA homologs are expected to 
follow a similar course as mentioned above.  They all share a common fold at the 
cleavage site region (β strand b3-loop-β strand b4 motif) and a ser-lys dyad catalytic 
mechanism when compared to the LexA crystal structure (Luo et al., 2001). 
 
Figure 2.2. The conformation-equilibrium model for LexA self-cleavage and RecA-
mediated cleavage. 
The model represents two interconvertible conformations of LexA, a non-cleavable 
conformation (L) and a cleavable conformation (L*) that can exist in the presence or 
absence of RecA.  The interconversion between the two conformations is controlled 
by the specific local environment around the active site residues (S119 and K156).  
The ratio [L*]/[L] is defined by the equilibrium constant (Kconf), and the self-
cleavage of LexA in the L* form follows a first ordered rate constant (kref).  P 
represents the cleavage products of the reaction.  (The figure was modified from 
Roland et al., 1992). 
 
 
Figure 2.3.   A cartoon picture depicting the two interconvertible conformations of 
the LexA homodimer. 
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In the top subunit, LexA exists in the non-cleavable conformation when the 
positively charged ε-amino group of K156 is exposed to the solvent.  In the 
bottom subunit, LexA exists in the cleavable conformation when the cleavage site 
region (orange) buries and deprotonates the ε-amino group of K156. (The figure 
was modified from Luo et al., 2001). 
As mentioned above, the self-cleavage mechanism in LexA consists of a ser-lys 
dyad that is conserved among certain ser-lys proteases (Luo et al., 2001; Slilaty and 
Little, 1987; Slilaty and Vu, 1991).  In the LexA protein, the ε-amino group of K156 is 
deprotonated and buried in the oxyanion hole, which serves as a general base to increase 
the nucleophilicity of S119 that is responsible for the cleavage of the A84-G85 peptide 
bond (Figure 2.4).  The end products for this cleavage reaction are an N-terminal DNA 
binding domain and a C-terminal fragment (Little, 1993).  The loss of the C-terminal 
(dimerization) domain reduces the N-terminal DNA binding domain’s affinity for its 
operator site and also its half-life (Bertrand-Burggraf et al., 1987; Little, 1983).  This 
allows the two DNA strands to melt (Silva and Silveira, 1993) and allow the bound RNA 
polymerase to isomerize from a closed to an open complex (Vershon et al., 1987), in 
order to transcriptional derepress the SOS genes. 
 
Figure 2.4.   The catalytic mechanism proposed for the self-cleavage of the LexA 
repressor. 
(The figure was modified from Slilaty and Little, 1987). 
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2.2.3. SOS Mutagenesis 
SOS mutagenesis is an error-prone replication process that allows specific types 
of UV-induced DNA lesions to be bypassed by the DNA repair machinery (Walker, 
1985).  Initiation of this process involves the transcriptional derepression of the SOS 
operon; this includes the cleavage of the LexA repressor at the umuDC operon in order to 
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produce UmuD and UmuC.  These proteins are able to associate and form an 
UmuD2UmuC heterotrimer, which is responsible for initiating the DNA damage cell 
cycle checkpoint (Opperman et al., 1999).  In the presence of the activated RecA 
nucleofilament, UmuD undergoes RecA-mediated cleavage (removal of its N-terminal 24 
amino acids) to generate either a UmuD/UmuD’ heterodimer or a UmuD’2 homodimer 
(Burckhardt et al., 1988; Nohmi et al., 1988; Shinagawa et al., 1988).  The 
UmuD’2UmuC heterotrimer constitutes a functional DNA polymerase V that is 
responsible for bypassing DNA lesions that can not be replicated by DNA Polymerase III 
(Reuven et al., 1999; Tang et al., 2000; Tang et al., 1999).  Once the regions of the DNA-
damaged bases are filled in, the RecA nucleofilament can no longer mediate the cleavage 
of UmuD.  The remaining UmuD’-UmuD heterodimers lead to the inhibition of 
translesion synthesis (Battista et al., 1990).  Eventually, they are removed from the cell 
by the ATP-dependent protease, ClpXP, which turns off SOS mutagenesis (Gonzalez et 
al., 2000). 
2.2.4. Homologous Recombination 
The pairing and complete exchange of DNA strands occur in a series of 
kinetically defined steps (Figure 2.5) (Kowalczykowski, 1987b).  In the first step, 
presynapsis requires the formation of a stoichiometric complex of RecA proteins and 
ssDNA (where one RecA monomer will bind to 3-4 nucleotide residues in a 5’ to 3’ 
direction), which is facilitated by single-stranded DNA binding protein (SSB).  In the 
second step, synapsis requires the binding of the RecA/ssDNA complex to dsDNA, 
where the first contacts are not necessarily homologous in nature.  This leads to a 
nonhomologous paired complex known as coaggregates that is responsible for increasing 
the local concentration of DNA, and in turn increases the rate of homologous pairing 
(Gonda and Radding, 1986).  Following homologous alignment, there are two types of 
joint molecules that can form depending on the topological constraints.  (1) Paranemic 
joints occur when the incoming ssDNA is not topologically intertwined at the internal site 
of the complementary dsDNA.  (2) Plectonemic joints occur when the incoming ssDNA 
winds freely around the ends of the complementary dsDNA.  The final step involves 
RecA-mediated branch migration, where the heteroduplex region in the joint molecule is 
extended unidirectionally (5’ to 3’ direction relative to the incoming ssDNA) until the 
complete exchange of the ssDNA occurs. 
 
Figure 2.5. A schematic representation of the DNA strand exchange reaction 
catalyzed by RecA. 
A simplified version of the kinetic steps involved in the protein-catalyzed exchange of 
DNA strands between circular single-stranded and linear double-stranded DNA 
molecules in the presence of SSB protein.  Upon complete exchange of DNA strands, 
the linear ssDNA and nicked (or gapped) circular dsDNA products are formed.  (The 
figure was taken from Kowalczykowski, 1991). 
2.3. The Role of RecA’s ATPase Activity 
All of RecA’s biological activities require the presence of ATP, which is 
responsible for the allosteric transition into a conformation that is referred to as a “high-
affinity DNA binding state” (Menetski and Kowalczykowski, 1985).  Under these 
conditions, the RecA nucleofilament has an extended helical pitch of >95 Å with an 
average of 6.2 subunits per turn (Figure 2.6) (DiCapua et al., 1992; DiCapua et al., 
1990b; Yu et al., 2001).  This extension in the RecA/ATP filament is correlated to its 
tight binding affinity for ssDNA, which in turn is able to promote DNA strand-exchange 
activities and mediate the cleavage of some ser-lys proteases. 
The binding of ATP and not its hydrolysis has been found to promote RecA’s 
DNA strand exchange reaction (Menetski et al., 1990).  For example, less than 3 x10-3 
molecules of ATP-γ-S are hydrolyzed per base pair of DNA heteroduplex formed in 3.4 
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kb pairs of DNA heteroduplex.  Thus, the slowly hydrolysable ATP analog, ATP-γ-S 
[adenosine-5’-O-(3-thiotriphosphate)] is able to promote RecA’s DNA strand exchange 
activities with no input of free energy (Cox and Lehman, 1981; Honigberg et al., 1985; 
Menetski et al., 1990; Riddles and Lehman, 1985) because the reaction is isoenergetic 
(i.e. the free energy of the substrates and products are identical, because the number of 
base pairs is conserved through the reaction) (Kowalczykowski, 1991).  The free energy 
in the DNA strand-exchange step is obtained from the binding of ATP, which results in 
an allosteric conformational change.  The energy derived from the binding of ATP is 
required for the input of free energy in: (a) displacing SSB protein from ssDNA, (b) 
unwinding of dsDNA, and (c) pairing and stabilizing the three-stranded DNA 
intermediate (Kowalczykowski, 1991). 
In the absence of ATP or in the presence of ADP, the RecA filament exists in a 
“low-affinity DNA binding state” (Menetski and Kowalczykowski, 1985).  Under these 
conditions, the RecA filament has a collapsed helical pitch of <82 Å with an average of 
6.4 subunits per turn (Figure 2.6) (DiCapua et al., 1990b; Story et al., 1992; Yu et al., 
2001).  This collapse in RecA’s helical structure is correlated with its low DNA binding 
affinity (Menetski and Kowalczykowski, 1985), which allows RecA to dissociate from 
the DNA (i.e. the displacement of DNA strands). 
               
Figure 2.6.   The inactive and active structure of the RecA filament. 
(a) The active state of the RecA filament (complex with ssDNA and ATP-γ-S) has 
an extended pitch of ~100 Å.  (b) The inactive state of the RecA self-polymer has a 
compressed pitch of ~70 Å.  (The figure was modified from DiCapua et al., 1990). 
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In general, the hydrolysis of ATP to ADP accomplishes two tasks: (1) it destroys 
the ATP effector molecule and (2) it produces a new ADP effector molecule 
(Kowalczykowski, 1991).  It also solves the “tight binding dilemma” for a protein that is 
expected to bind tightly to its DNA substrate and yet be able to dissociate and act on a 
different molecule (Kowalczykowski, 1987a). 
2.3.1. Regulating RecA’s Coprotease Activity 
The same allosteric conformational changes that are associated with RecA’s DNA 
strand-exchange activities upon ATP binding can also be applied to its coprotease 
activity.  Based on small angle neutron scattering and electron microscopy studies, 
RecA’s coprotease activity is correlated to the extended helical pitch that is seen for 
RecA/ATP nucleofilaments (i.e. >95 Å with an average of 6.2 subunits per turn) 
(DiCapua et al., 1992; VanLoock et al., 2003a; Yu and Egelman, 1992).  Also, the 
binding of ATP-γ-S in the presence of high salt concentrations can stimulate RecA’s 
coprotease activity that would otherwise require ssDNA preactivation (DiCapua et al., 
1990a).  Thus, the extended helical pitch of the RecA filament is a requirement for its 
coprotease activity, no matter how these allosteric conformational changes are brought 
about. 
Theses changes may be responsible for the spacing within the helical groove of 
RecA in order to accommodate the LexA repressor (Story et al., 1992; Yu and Egelman, 
1993) and also a hydrophobic environment in order to shift LexA’s conformation towards 
the cleavable form (Lin and Little, 1989).  Thus, the formation of a stable RecA/LexA 
complex requires the extended helical pitch of RecA (DiCapua et al., 1992) and it may 
also require the cleavable form of the LexA protein (Luo et al., 2001). 
The structural changes associated with the hydrolysis of ATP to ADP will most 
likely decrease the spacing within the helical groove of RecA, as a result of the collapse 
in its helical pitch (Yu and Egelman, 1992).  Thus, the RecA/ADP nucleofilament is not 
expected to bind to the incoming LexA repressor nor mediate its self-cleavage, since the 
repressor will not be able to fit inside RecA’s helical groove. 
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2.4. Modulating the Structure and Stability of the RecA/DNA Complex by 
Nucleotide Cofactors 
2.4.1. Structural Transitions in the RecA/DNA Complex 
The electron microscopy images of the RecA/DNA complex shows a structure 
that is filamentous, and a morphology that is dependent on the nucleotide cofactor present 
(DiCapua et al., 1992; Heuser and Griffith, 1989; Yu and Egelman, 1992).  In the 
absence of a nucleotide cofactor or in the presence of ADP, the complex has a compact 
helical pitch of 55-83 Å (Heuser and Griffith, 1989; Story et al., 1992; Yu and Egelman, 
1992).  This compact helical pitch is also consistent with the small-angle neutron 
scattering studies, but the complex is formed in the absence of ATP and in the presence 
or absence of ssDNA (DiCapua et al., 1990b).  Based on the electron microscopy and 
small-angle neutron scattering studies, the compact structure is able to accommodate six 
nucleotide residues per RecA monomer.  Also in the same study, the RecA/DNA 
complex in the presence of either ATP or ATP-γ-S has an extended helical pitch of ~100 
Å that is able to accommodate three nucleotide residues per RecA monomer.  Thus, the 
data suggest that the conformation of the RecA nucleofilament can exist in two different 
structures, a compact or extended state.  Additionally, the ATP-dependent transition into 
the extended state cannot occur in the absence of ssDNA.  Therefore, the extended state 
of the RecA/ATP complex requires the preactivation by ssDNA. 
The extension of RecA/ATP complexes upon ssDNA binding has also been 
observed with various binding assays.  For example, the RecA protein has been studied 
with the fluorescent properties of etheno M13 ssDNA.  The fluorescence of the etheno 
M13 DNA is found to increase upon binding of the RecA filament (Menetski and 
Kowalczykowski, 1985; Silver and Fersht, 1982, 1983).  (The secondary structure of the 
etheno DNA has no effect on the binding parameters).  The ratio of the fluorescence of 
the saturated RecA/etheno M13 DNA complex to RecA-free DNA [referred to as the 
relative fluorescence increase; (RFI)] is dependent on the nucleotide cofactor used 
(Menetski and Kowalczykowski, 1985; Silver and Fersht, 1982).  In the presence of ADP 
or in the absence of a nucleotide cofactor, the RFI value is low; while in the presence of 
ATP or ATP-γ-S, the RFI value is high (Menetski and Kowalczykowski, 1985).  The 
interconversion between the two RFI values can occur by allowing ATP to hydrolyze into 
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ADP.  These changes correspond to different conformations that are consistent with the 
structural data mentioned earlier (Kowalczykowski, 1991), since the changes in etheno 
fluorescence occur upon nucleotide base unstacking (Leonard, 1984).  Therefore, either 
structural or DNA binding methods are able to detect a compact or an extended helical 
structure that is dependent on the nucleotide cofactor used. 
2.4.2. Stability of the RecA/ssDNA complex 
As mentioned above, the nucleotide cofactor not only affects the conformation of 
the RecA/DNA complex, but also its stability (Menetski and Kowalczykowski, 1985).  
The stability of the complex has been examined by salt titration midpoint (STMP) 
(Kowalczykowski, 1986), where the salt concentration is quantitated for the amount that 
is required to dissociate half of the RecA/DNA complex.  For example, the STMP for the 
RecA/DNA-free form is 450 mM NaCl for 0.5 mM ATP, >2.5 M NaCl for 0.5 mM ATP-
γ-S, and 160 mM for 0.5 mM ADP.  The STMP values also display ligand binding-
specificity, since the ligand concentrations are hyperbolic for ADP (Menetski and 
Kowalczykowski, 1985) and sigmoidal for ATP (Menetski et al., 1988).  Thus, relative to 
the ligand free form, ATP or ATP-γ-S increases whereas ADP decreases the stability of 
the RecA/DNA complex. 
2.5. Modulating RecA’s DNA Binding Affinity with Nucleotide Cofactors 
The binding affinity of adenine-containing nucleotide cofactors is correlated to 
their effectiveness in inducing the high-affinity DNA state of RecA as follows: ATP-γ-S 
> dATP > ATP > AMP-PNP >>AMP-PCP (Kowalczykowski, 1986).  This correlation is 
also true for the binding affinity of other nucleotide triphosphate (NTP) cofactors 
(Kowalczykowski, 1991).  The hierarchy implies that there is a relationship between the 
binding affinity of ATP substrate, the induction of the high affinity state, and RecA 
strand-exchange activities.  These relationships can be easily understood in context to a 
model, which links the free energy of nucleotide binding to both DNA binding affinity 
and structural transitions (Figure 2.7) (Menetski et al., 1988).  The hierarchy arises from 
the fact that the total free energy (derived from nucleotide binding) is influenced by the 
binding constant and free nucleotide concentration (Kowalczykowski, 1991).  This 
implies that a higher concentration of NTP is  required for a NTP that has a lower binding 
affinity (discussed below). 
 
Figure 2.7. ATP concentration-dependent changes in RecA’s structure, 
stability and ssDNA binding affinity. 
Open circles represent nucleotide-fee RecA protein; circles labeled T 
represent the RecA/ATP complex; orange lines represent ssDNA; and 
shaded circles represent the different conformations of the RecA/ATP 
complex.  Each step represents the steady-state properties.  (The figure 
was modified from Kowalczykowski, 1991). 
 
The binding of ATP by free protein (Kd ~15 µM) or by RecA/DNA complex (Kd 
~ 2.5 µM) is a thermodynamic process (Kowalczykowski, 1986).  This is also true for the 
binding of ADP, but it decreases RecA’s affinity for ssDNA (Cotterill et al., 1982).  On 
the other hand, ATP hydrolysis shows a sigmoidal dependence on ATP concentrations 
(S0.5 ~60 µM) and is not detectable until a concentration of 25 µM ATP is achieved 
(Menetski and Kowalczykowski, 1987).  As the concentrations of ATP are increased, 
there is a change in the stability and structure of the RecA/DNA complex.  This structural 
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transition has a higher affinity for ssDNA and a sigmoidal dependence on ATP 
concentrations (>100 µM).  An even more stable RecA/DNA complex occurs at higher 
ATP concentrations (Menetski et al., 1988), resulting in a fully extended structure that 
has a hyperbolic dependence on higher ATP concentrations (Kd ~125 µM).  Thus, all of 
these changes must involve independent structural changes because their dependence on 
ATP concentrations is different at each stage (Kowalczykowski, 1991). 
Apparently all of these transitions are required in the formation of an active 
presynaptic complex (Kowalczykowski, 1991), however, there is no evidence to suggest 
that these transitions are required for RecA’s coprotease activity.  For example, RecA is 
able to hydrolyze other NTPs in a DNA-dependent manner, such as dUTP, UTP, dCTP 
and CTP (Weinstock et al., 1981b).  The binding affinities for these NTPs are sufficient 
to promote RecA-mediated cleavage of the lambda repressor (Phizicky and Roberts, 
1981), but not sufficient to promote its DNA strand exchange activity (Kowalczykowski, 
1991).  These results suggest that the binding of NTPs is able to facilitate the extended 
state of the RecA/DNA complex, but further structural transitions that are associated with 
the binding of either ATP or dATP (in RecA’s DNA strand exchange activity) may not 
be required for its coprotease activity. 
2.6. Subunit Rotations in the Active RecA/ssDNA/ATP Complex 
Spectroscopic evidence for the RecA filament formed on ssDNA in the presence 
of ATP-γ-S indicates that there are significant rotations in the subunits with respect to the 
RecA crystal filament (Morimatsu et al., 2002).  A change in angle of ~15º for 20 dipole 
moments was observed between these transition moments relative to the axes of the 
active filament and the RecA crystal structure (Morimatsu et al., 2002).  These large 
changes were also consistent with the building of the RecA filament model (VanLoock et 
al., 2003b), which lead to very different subunit-subunit interface than that seen with the 
RecA crystal filament. 
2.7. Residues involved in ATP Binding 
The residues K216, F217, R222, K248, K250, and P254 are conserved among all 
bacterial RecA sequences (Karlin and Brocchieri, 1996), but they are not in close contact 
with ATP in the RecA crystal structure (Story et al., 1992).  In the electron microscopy 
generated RecA filament model, the six residues are situated on the adjacent subunit and 
in close proximity to the triphosphate of ATP (Figure 2.8) (VanLoock et al., 2003b).  
Mutations at the residues K216, F217, and R222 had been found to impair RecA’s 
ATPase activity and filament formation in the absences of ssDNA (Logan et al., 1997; 
Skiba and Knight, 1994).  Additionally, replacing Phe-217 with Tyr in the RecA filament 
model allows the OH group on the phenylalanine ring to be in close proximity to the ATP 
phosphate backbone and potentially act as a H-bond donor (VanLoock et al., 2003b). 
This is supported by other studies, where the F217Y mutant was found to enhance 
RecA’s DNA recombination and SOS induction in vivo (Skiba and Knight, 1994), and 
ATP-mediated filament assembly in vitro (De Zutter et al., 2001).  Also, disulfide 
mutations at RecA’s subunit interface place the F217C mutant near the ATPase core in 
vitro (Skiba et al., 1999).  The remaining residues (K248, K250, P254) in the RecA 
filament model were in close proximity to the adenosine base of ATP in the adjacent 
subunit (VanLoock et al., 2003b).  It is suggested that the K248 residue interacts with 
ATP in trans (Wu et al., 2005), since the K248R/E96D double mutant partially restores  
 
 
a. b.
Figure 2.8. Location of the six conserved residues in the RecA 
filament model and crystal structure. 
(a) In the RecA filament model, the six conserved residues found 
in all of the bacterial RecA proteins (216, 222, 248, 250, and 254 
in green; and 217 in magenta) are interacting with the ATP 
substrate (yellow) on the adjacent subunit interface.  (b) On the 
other hand, the RecA crystal structure, the six conserved residues 
are situated away from the ATP substrate.  (The figure was 
modified from VanLoock et al., 2003b). 
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ATP hydrolysis (Cox et al., 2006).  Also, single point mutations at K248 reduces the rate 
of ATP hydrolysis, ssDNA binding and filament formation (Nguyen et al., 1993).  In 
general, the RecA filament model suggests that the six conserved residues make 
important contacts with ATP, and provide stabilization at the subunit-subunit interface 
(i.e. important in filament formation).  The residues in the crystal structure, on the other 
hand, are not involved in subunit-subunit contacts that are associated with the bound ATP 
(Story et al., 1992). 
2.8. Filament Assembly in RecA and RecA-homologs 
In a recent paper published by our lab, the crystal structure for methanococcus 
voltae RadA (MvRadA; a RecA homolog) confirmed the location of the six conserved 
residues in the RecA filament model (K216, F217, R222, K248, K250, and P254), and 
also their role in ATP-mediated filament formation.  The counterpart residues in 
MvRadA (G279, H280, R285, D302, H305, and P307) are in close proximity to the 
bound ATP analog (Wu et al., 2004).  Additionally, the ATP substrate is bridged by the 
solvent rich interface, which explains why filament assembly is extremely sensitive to 
ATP hydrolysis, and the variations in helical pitch that is observed for all documented 
RecA-homologs (Wu et al., 2004). 
2.9. The MvRadA-based RecA Dimer Model 
The crystal structure of MvRadA was also used to generate an MvRadA-based 
RecA dimer model (RecA dimer model) on the conserved ATPase cores and C-terminal 
domains of EcRecA.  The RecA dimer model was found to be structurally similar to the 
electron microscopy RecA filament model (3.5 Å RMSD), while both RecA dimer and 
RecA filament models had very little structural similarities with the EcRecA crystal 
structure (6.5 Å and 7.2 Å respectively; Figure 2.9) (Wu et al., 2004).  Additionally, both 
models have an extended helical pitch (~106 Å for MvRadA and 91 Å for EcRecA) that 
is associated with the active form of RecA, while the crystal structure of the RecA/ADP 
complex has a collapsed helical pitch of 82 Å that is associated with the inactive form of 
RecA.  Therefore, these models may represent an allosteric conformational change that is 
associated with the active form of RecA.  On the other hand, the crystal structure of the 
RecA/ADP complex represents an allosteric conformational change that is associated 
with the inactive form of RecA. 
 
a. b. c.
In the RecA dimer model, three out of the six conserved residues (K248, K250, 
and P254) are situated in close proximity to the ATP analog/ATP core (residues 302-308) 
on the adjacent subunit, and the remaining conserved residues (K216, F217, and R222) 
are more distant from the phosphate backbone of the ATP analog when compared to the 
RecA filament model.  The latter differences may be attributed to the potential allosteric 
conductance site at the helix G region that harbours the conserved residues (e.g. F217Y 
mutant increases the hyper-activity of RecA’s ATPase activity).  In general, the 
MvRadA-based and RecA filament model place the helix G region within the vicinity of 
the phosphate backbone of the ATP analog.  Also, the N-terminal region of the ATPase 
core between bacterial and non-bacterial recombinases are structurally different, which 
may suggest an allosteric effect or simply a difference in orientation (Wu et al., 2004).  
There is evidence to support the former since the N-terminal region is sensitive to trypsin 
digestion, which suggests that the region is exposed and flexible (Mikawa et al., 1998; 
VanLoock et al., 2003b). 
The ATPase cores of EcRecA are shown in ribbons, and the AMP-PNP 
substrates are shown in ball-and-stick.  (a) The electron microscopy model for 
the active RecA filament, (b) the RecA dimer model for the active RecA 
filament, and (c) the crystal structure for the inactive RecA filament.  The 
electron microscopy and RecA dimer models have a similar ATP-mediated 
interface and disposition of the helix G motif/L2 region.  While the RecA 
crystal structure does not resemble either one of the two models.  (The figure 
was taken from Wu et al., 2004). 
Figure 2.9. The different conformations adopted at RecA’s ATPase core. 
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2.10. Allosteric Changes in MvRadA 
The differences between archaeal/eukaryal and bacterial recombinases are the 
location of the implicated dsDNA binding domain and cation dependent activity.  RadA 
is known to be a stringent K+-dependent ATPase, any other monovalent cation results in 
a 200-fold decrease in its ATPase activity (Wu et al., 2005).  The ATPase activity of 
MvRadA, EcRecA, yeast, and human Rad51 can also be stimulated by high salt 
concentrations, since the anionic species are believed to mimic the polyanionic phosphate 
backbone of DNA (Liu et al., 2004; Pugh and Cox, 1988; Tombline et al., 1990; Wu et 
al., 2005). 
In the MvRadA K+-rich crystal structure, the L2 region (N256-R285) becomes 
ordered and there is a conformational change in the helix G region (G275-A282) (Wu et 
al., 2005).  At the helix G region, the side chain of H280 (equivalent F217 in EcRecA) 
forms a hydrogen bond with the γ-phosphate of the ATP analog.  Also, the R285-F107 
cation-π pair is partially vacated to allow two K+ ions to be incorporated near the γ-
phosphate binding site, which bridges the γ-phosphate with the carbonyl moieties at the 
C-terminus of the helix G region.  This allows the γ-phosphate to make extensive contacts 
around the Helix G/L2 region with: a hydrogen bond by H280, a K+ bridge with the helix 
G harbouring the H280 residue and a water nucleophile that is hydrogen bonded with the 
Q257 residue, and another separate K+ bridge with the D302 residue (Wu et al., 2005).  
Thus, there is a long-range conformational change upon binding of K+ ions, which orders 
and stacks the putative ssDNA-binding L1 and L2 regions along the helical axis.  These 
conformational changes suggest that there is cross-talk between the binding of potassium 
at the ATP site and the ssDNA-binding L2 region (Wu et al., 2005). 
RecA and other bacterial homologs do not require monovalent cations.  The 
crystal structures of RecA-like homologs reveal that cationic side chains on the adjacent 
subunit make contact with the γ-phosphate in trans.  For example, the circadian clock 
protein KaiC has a Lys-Arg pair (K457 and R459) that makes contact with the γ-
phosphate in trans (Pattanayek et al., 2004).  Also, the RecA filament model has K248 
(equivalent D302 in MvRadA) and K250 in close proximity to ATP in the adjacent 
subunit (VanLoock et al., 2003b), and mutational studies suggest that K248 binds to ATP 
in trans (Cox et al., 2006).  Thus, the cationic side chains in the ATPase site of RecA and 
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RecA-like homologs make it unlikely for the protein to accommodate monovalent cations 
(Wu et al., 2005).  This may explain why RecA is able to maintain its ATPase activity in 
the absence of monovalent cations. 
2.11. ATPase Catalytic Mechanism in MvRadA 
The residues E151 and Q257 in MvRadA (equivalent to E96 and Q194 in 
EcRecA) are candidates for activating the hydrolyzing water (Story et al., 1992), because 
these residues form hydrogen bonds with water.  The residues are also found to cooperate 
with the P-loop motif (Wu et al., 2005) that is responsible for wrapping around the 
triphosphate of ATP and making amide-phosphate hydrogen bonds.  The contacts made 
at the ATP binding site by the ε-amino group of K111, side chain of H280, Mg2+ ion, and 
two K+ ions are likely to create an electron withdrawing effect on the oxygen atoms of 
the γ-phosphate of ATP (Figure 2.10a) (Wu et al., 2005).  This polarizes the γ-phosphate 
of the ATP analog, allowing for nucleophilic attack by the hydrolyzing water molecule.  
(This also justifies why MvRadA is a K+-dependent ATPase).  Following hydrolysis of 
ATP to ADP, a negative charge is expected to build up at the β-phosphate of the leaving 
ADP molecule.  The latter reaction is likely to be stabilized by the electron withdrawing 
Mg2+ ion; and the amide groups, along with the ε-amino group of K111 in the conserved 
P-loop motif (Figure 2.10b) (Wu et al., 2005). 
2.12. DNA Binding Domains in RecA 
In the RecA crystal structure, the disordered loop regions, L1 (residues 157-164) 
and L2 (residues 195-209), were proposed to be the secondary dsDNA and primary 
ssDNA binding sites respectively (Story et al., 1992).  This proposal was based on 
various mutagenesis studies on the L1 and L2 regions of RecA.  For example, the single 
point mutant, RecA E207Q (L2 region) was found to inhibit SOS response and 
homologous recombination activities in vivo (Larminat et al., 1992).  The mutant was 
found to be functional in its biochemical activities associated with primary ssDNA 
binding in vitro, but etheno DNA binding studies indicated that the mutant lacked one of 
the two ssDNA binding sites (Cazaux et al., 1998).  Also, mutagenesis studies on the L2 
residues (N193, Q194, R196, T209, G211, and G212) were found to lead to defects in  
 
 a. 
b. 
lambdoid bacteriophage recombination and recombinational DNA repair in vivo 
(Hörtnagel et al., 1999).  These two experiments suggest that the L2 region is involved in 
primary ssDNA binding. 
(a) The residue E151 acts as a general base in the activation of the 
hydrolyzing water molecule, and E151 and Q257 form hydrogen bonds 
with the hydrolyzing water molecule, in order to align it for nucleophilic 
attack.  On the other hand, K111, H280, Mg2+ ion and the two K+ ions 
polarize the γ-phosphate of ATP.  (b) Following hydrolysis of ATP, the 
Mg2+ ion and K111 stabilizes the negative charge build up at the β-
phosphate of ADP.  (The figure was modified from Wu et al., 2005). 
Figure 2.10. The proposed catalytic mechanism for ATP hydrolysis. 
On the other hand, the single point mutations at the L1 region in RecA were found 
to have constitutive coprotease activity (i.e. indicating that RecA has a ssDNA-dependent 
ATP hydrolysis), but lacked recombination in vivo (Wang and Tessman, 1986).  This 
implies that the primary ssDNA site is functional, while the secondary dsDNA site is 
defective.  Therefore, the L1 region may be involved in secondary dsDNA binding.  
Finally, a double substitution at the L1 region (E156L and G157V) in EcRecA was found 
to reduce the level of recombination and constitutive coprotease behaviour in vitro 
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(Mirshad and Kowalczykowski, 2003).  This suggests that the L1 region is involved in 
both primary ssDNA and secondary dsDNA binding. 
The L2 region in RecA has also been defined by a synthetic peptide (residues 
193-212).  This peptide was able to bind to ssDNA cooperatively (Gardner et al., 1995), 
form a secondary structure in the presence of ssDNA (Selmane et al., 1999), and promote 
joint molecule formation between single-stranded oligonucleotides and a homologous site 
on dsDNA (Voloshin et al., 1996).  Cross-linking studies with 5-iodouracil 
oligonucleotides on synthetic peptides containing either L1 or L2 regions were found to 
be covalently linked at the amino acid residues M164 (L1 region) and M202 (L2 region) 
(Malkov and Camerini-Otero, 1995).  These results suggest that both L1 and L2 regions 
may be involved in primary ssDNA binding.  It is also worth mentioning that the 
functional 5-iodouracil base and the reactive amino acid are cross-linked, because of the 
close proximity between each group (4-5 Å in distance) (Dong et al., 1994).  Thus, RecA 
is most likely to bind to the phosphodiester backbone of DNA rather than to the 
nucleotide base that is positioned for homologous pairing (Leahy and Radding, 1986). 
In general, the majority of the research on the DNA binding sites suggests that the 
L1 region is involved in secondary dsDNA binding and possibly primary ssDNA binding, 
while the L2 region is involved in primary ssDNA binding 
2.13. Homologous Strand Exchange in RecA and RecA-homologs 
The extended recombinase filament serves as a scaffold in facilitating strand 
exchange between primary ssDNA and secondary homologous dsDNA.  Given that this 
extended structure of the recombinase filament is conserved among archaeal, bacterial, 
and eukaryal organisms, this suggests that the conformation may have been shaped in 
order to accommodate the extended form of B-DNA for compatible homologous strand 
exchange (Egelman, 2001). 
The N-terminal domain of archaeal and eukaryal recombinases, and the C-
terminal domain of bacterial recombinase have lobes that are situated on a relatively 
smooth core filament between the associated ATPase domains.  However, these lobe-like 
domains between archaeal/eukaryal and bacterial recombinase are different in topology 
and are located on opposite rims in the respective core filaments.  NMR chemical shift 
perturbation mapping of the DNA binding and mutagenesis studies on a truncated N-
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terminal lobe in HsRad51 (a MvRadA homolog) show that the HhH motif has a 
positively charged surface, and that it is involved in the binding of dsDNA (Aihara et al., 
1999).  The spacing between HhH motifs is ~35 Å in the MvRadA K+-free crystal 
structure, which may allow for flexibility in the dsDNA to contact the axial ssDNA (Wu 
et al., 2004).  A similar surface patch has been found on the C-terminal lobe of EcRecA 
(residues G301 and K302) (Aihara et al., 1997), and mutations at the C-terminal domain 
of EcRecA (K286N and K302N) is found to reduce homologous pairing (Tateishi et al., 
1992).  In either of the cases, the structural studies on archaeal, eukaryal and bacterial 
recombinase all have a lobe region that is implicated in the binding of dsDNA, and they 
are all located outside of their respective filament axis (Aihara et al., 1997). 
In the MvRadA K+-free crystal structure, the subunit interface of the N-terminal 
elbow of L1 in one subunit, and the C-terminal elbow of L2 in the adjacent subunit are 
situated in close proximity to the helical axis (Wu et al., 2004).  The special arrangement 
between the L1 and L2 regions implies that these regions are interacting directly with the 
ssDNA in the active filament.  In the presence of potassium, there is a long-range 
conformational change that orders and stacks the putative ssDNA-binding regions of L1 
and L2 along the helical axis, which creates a positively charged patch compatible for 
binding anionic DNA (Wu et al., 2005).  However, the exact role of the L1 and L2 
regions in the MvRadA K+-rich crystal structure are not clear, since the Cl- ions were not 
observed at these regions.  Thus, the arrangement of the DNA binding regions in 
MvRadA is consistent with the arrangement found in the RecA based and RecA filament 
models, and their role in ssDNA binding is also consistent with the biochemical studies 
(see section 2.12). 
The distance between HhH motifs and the L1 region is ~15 Å apart, which 
suggests that the L1 region may also be involved in the binding to dsDNA (Wu et al., 
2004).  This is also consistent with mutagenesis in PfRad5, where R251 in the L1 region 
(equivalent R224 in MvRadA) is implicated in dsDNA binding (Shin et al., 2003).  
Therefore, the results suggest that the dsDNA bound at the HhH motif may be brought 
into the groove through a wide opening in the filament axis, in order for the L1 region to 
bind to dsDNA in both EcRecA and MvRadA.  However, the different polarities for 
dsDNA binding in EcRecA and MvRadA suggests two possibilities.  (1) They utilize 
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different mechanisms and dsDNA binding lobes participate in ssDNA invasion into a 
homologous stretch of dsDNA.  (2) They share similar mechanisms, but the dsDNA lobes 
play a less direct role (Wu et al., 2004). 
Despite the weak sequence similarities, the MvRadA crystal structure and the 
active RecA filament model both have a similar structure, which suggests that the two 
proteins are structural homologs.  Therefore all RecA-like recombinases may have a 
conserved regulatory role at the ATPase core, which is responsible for re-orienting the L1 
and L2 regions for DNA strand exchange (Wu et al., 2004). 
2.14. RecA’s Binding Site for the LexA Repressor 
Based on the RecA crystal structure, a “notch” region, situated between adjacent 
lobes of RecA, has been proposed as the binding site for the LexA repressor (Story et al., 
1992).  The notch region is large enough to accommodate smaller proteins, and 
mutational studies on residues situated at this site are found to differentially affect RecA-
mediated cleavage of the LexA repressor and its homologs in vivo.  For example, R243L 
prevents cleavage of φ80 repressor and UmuD protein (Dutreix et al., 1989), and G229S 
prevents cleavage of φ80 repressor (Ogawa and Ogawa, 1986).  However, other residues 
at the notch region are also situated at the subunit-subunit interface in the active RecA 
filament model.  For example, S25F (Wang and Tessman, 1986) and C116S (Weisemann 
and Weinstock, 1988) mutations lead to a constitutive coprotease activity for LexA 
homologs, and S117F (Dutreix et al., 1989) leads to a defective coprotease activity for 
the LexA repressor.  When these residues are examined in the active RecA filament 
model, they are situated at the subunit-subunit interface.  Therefore, the latter mutations 
are not likely to play a direct role in RecA’s coprotease activity. 
Based on the electron microscopy studies on the RecA/LexA complex (VanLoock 
et al., 2003a; Yu and Egelman, 1993), LexA appears to be in close proximity to some 
areas in the notch region (residues 229 and 243) and the secondary DNA-binding site 
(residues 154-156 and 165; i.e. L1 region [residues 157-164]).  This can be seen in the 
reconstituted/modified crystal density diagram (Figure 2.11).  The residues implicated in 
the binding of LexA are also consistent with mutational studies on RecA’s coprotease 
activity, such as R243L (Dutreix et al., 1989), G229S (Ogawa and Ogawa, 1986) and 
G154-E158 substitutions (Nastri et al., 1997).  Therefore, LexA appears to be binding at 
both the inner surface of the C-terminal lobe and the N-terminal L1 region of RecA (Yu 
and Egelman, 1993). 
The inability for the inactive RecA filament to promote the mediated cleavage of 
the LexA repressor can be explained by the overlap of electron density observed when  
the LexA subunit is positioned within the RecA crystal and the electron microscopy 
structures (Yu and Egelman, 1993).  Therefore, the LexA repressor is unable to fit into 
the compressed helical groove of RecA. 
Interestingly, the regions that are implicated in dsDNA binding (L1 region; and 
C-terminal lobe, residues 268 to 330) are also within the binding vicinity of the LexA 
repressor.  This may explain why dsDNA (Takahashi and Schnarr, 1989) and high 
concentrations of ssDNA (Rehrauer et al., 1996) are able to inhibit RecA-mediated 
cleavage of the LexA repressor.  It also may explain why the non-cleavable LexA S119A 
mutant is able to act as a competitive inhibitor in RecA’s DNA strand exchange activities 
(Harmon et al., 1996).  
 
a. b.
(a) The 3-dimensional surfaces of the RecA-dsDNA filament (light gray) and 
the helically averaged LexA repressor difference density (dark gray) within 
the helical groove of RecA.  The superimposition of the two structures 
generates the density of the LexA repressor with an apparent binding 
stoichiometry 1:1 (RecA:LexA).  The arrows that are labeled as A indicate the 
position of the strong contacts, which corresponds to the residues 229 and 243.  
(b) A low resolution of the RecA crystal structure with the approximate 
positions of the residues 229, 243, 156 and 165 that are in close proximity to 
the LexA repressor.  (The figure was modified from Yu and Egelman, 1993). 
Figure 2.11. The electron microscopy image of the RecA/LexA complex. 
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3. OBJECTIVES 
The overall objective of this study was to examine the thermodynamic model for 
the formation of the RecA/LexA complex by reducing the energy barrier involved at each 
step in the thermodynamic process. 
To achieve this goal, the energy barrier at each step was reduced by: 
(1) High salt concentrations and/or a hyper-active RecA mutant in 
order to preactivate RecA. 
(a) A non-cleavable LexA mutant was used as bait in the yeast 
two-hybrid system, in order to isolate a hyper-active RecA 
mutant. 
(2) LexA S119A and K156A in order to influence LexA’s 
conformation. 
(3) A volume-excluding agent (polyethylene glycol) in order to force 
the binding between the preactivated RecA protein and the 
cleavable conformation of LexA. 
(4) Introducing different single-point mutations at LexA’s dimer 
interface, in order to determine RecA’s preference for the 
monomer or dimer form of LexA.  This experiment was also 
related to the thermodynamic model, since the dimer or monomer 
form of LexA was expected to influence the energy barrier 
involved in the formation of the RecA/LexA complex. 
 
 
4. MATERIALS AND METHODS 
4.1. Cell lines 
The strains used in the yeast monohybrid system were S. cerevisiae strain EY111 
(MATα his3 trp1 ura3::URA3-LexA8op-lacZ ade2::URA3-LexA8op-ADE2 
leu2::LexA6op-LEU2) and S. cerevisiae strain EY93 (MATa ura2 his3 trp1 leu2 
ade2::URA3).  Both yeast strains were a gift from Dr. Geyer’s Lab.  The E. coli strain 
XL1-Blue (electroporation-competent) (Stratagene) was used in making multiple copies 
of the plasmid of interest, and E. coli strain BL21 (DE3) (Novagen) was used in 
producing the protein of interest. 
4.2. Materials 
The items mentioned in the materials and methods are listed in Table 4.1. 
 
Table 4.1.   A list of items used in the experimental procedures. 
Item Supplier 
  
Chemicals and Reagents  
  
ATP Sigma 
ATP-γ-S Sigma 
AMP-PNP Sigma 
Agarose Invitrogen Life Technologies 
Acetic acid, glacial EMD Chemicals Inc 
Acrylamide, electrophoresis grade Sigma 
Ammonium persulfate EMD Chemicals Inc 
Ammonium sulfate EMD Chemicals Inc 
Ammonium molybdate EMD Chemicals Inc 
Ampicillin, sodium salt BioShop 
Bradford reagent Bio-Rad 
Bromophenol blue Alfa Aesar 
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Chloroform Amresco 
Coomassie Brilliant Blue R-250 AnaSpec 
Dimethyl formaldehyde Laboratory Plus 
dNTP set Amersham Biosciences 
Ethidium Bromide Sigma 
Ethyl alcohol 95% Commercial Alcohols Inc. 
EDTA (ethylenediaminetetraacetic acid) EMD Chemicals Inc 
D-Galactose BD Biosciences 
Glycerol EMD Chemicals Inc 
Hydrochloric acid BDH Inc. 
HEPES (N-2-hydroxyethylpeperazine-N'-2-
ethane-sulfonic acid) 
BioShop 
Imidazole Avocado Research Chemicals ltd
Isoamyl alcohol Amresco 
Isopropyl alcohol EMD Chemicals Inc 
IPTG (Isopropyl-thio-β-D-galactoside) EMD Chemicals Inc 
Kanamycin sulfate Bioshop 
Lithium acetate EMD Chemicals Inc 
Malachite green oxalate Avocado Research Chemicals 
Inc. 
Magnesium chloride, hexahydrate EMD Chemicals Inc 
Magnesium sulfate EMD Chemicals Inc 
MES [2-(N-morpholino)-ethane sulfonic acid 
monohydrate] 
EMD Chemicals Inc 
2-Mercaptoethanol Bioshop 
Nickel sulfate, hexahydrate EMD Chemicals Inc 
Phenol Amresco 
Polyethylene glycol 400 Fluka Chemical 
Polyethylene glycol 3500 Fluka Chemical 
Potassium phosphate, dibasic EMD Chemicals Inc 
Potassium dihdrogen orthophosphate BDH Inc. 
Saccharose EMD Chemicals Inc 
Sodium chloride EMD Chemicals Inc 
SDS (sodium dodecyl sulfate) Calbiochem 
Sodium hydroxide EMD Chemicals Inc 
Sucrose EMD Chemicals Inc 
TRIS [Tris (hydroxymethyl) aminomethane] EMD Chemicals Inc 
Urea EMD Chemicals Inc 
X-Gal (5-bromo-4chloro-indoyl-β-D-
galactopyranoside) 
Eppendorf 
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Media  
  
Agar BD Biosciences 
LB agar EMD Chemicals Inc 
LB Miller broth EMD Chemicals Inc 
Peptone BD Biosciences 
Yeast extract BD Biosciences 
Yeast nitrogen without amino acids BD Biosciences 
CSM, drop out supplements Biol 101 Inc 
  
Enzymes & Enzyme Buffers  
  
10X DNA ligase buffer MBI Fermentas 
10X Thermopol reaction buffer New England Bio Labs 
BamH I New England Bio Labs 
10X Buffer R MBI Fermentas 
EcoR I New England Bio Labs 
Nco I MBI Fermentas 
10X NEBuffer #2 New England Bio Labs 
Pfu DNA polymerase MBI Fermentas 
T4 DNA Ligase MBI Fermentas 
Taq DNA polymerase New England Bio Labs 
Thrombin Sigma 
Xho I MBI Fermentas 
  
Equipment & Miscellaneous Items  
  
ÄKTA Prime Protein Purification System Amersham Biosciences 
Allegra X-22R Centrifuge Beckman Coulter 
Avanti J-25 Centrifuge Beckman Coulter 
Centrifuge 5415 Eppendorf 
DU-40 Spectrophotometer Beckman Coulter 
Electroporator 2510 Eppendorf 
Falcon tube, 50 ml Becton Dickinson 
Glass beads, 425–600 µm in diameter Sigma 
HiPrep 16/60 Sephacryl S-100 High Resolution Amersham Pharmacia Biotech 
HiPrep 16/60 Sephacryl S-300 High Resolution Amersham Pharmacia Biotech 
Mastercycler Gradient Eppendorf 
 30
Micropipettors Biohit 
Micromass LTC Mass Spectrometer Waters Corp 
Orbit Environ Shaker Lab-Line 
Protein-Pak 125 Waters Corp 
QIAgen Miniprep Kit QIAgen 
QIAquick Gel Extraction Kit QIAgen 
QIAquick PCR Purification Kit QIAgen 
Sonic Dismembrator Model 500 Fisher Scientific 
Symmetry 400 C4 3.5 mm Waters Corp 
  
Resin  
  
DE52 anion exchanger, DEAE cellulose Whatman 
Chelating Sepharose fast flow Amersham Biosciences 
  
DNA  
  
pEG202 vector Dr. R. Geyer 
pET28a vector Novagen 
pJG4-5 vector Dr. R. Geyer 
ssDNA, dT36 Integrated DNA technologies Inc
ssDNA, spermadine trihydrochloride Sigma 
Synthetic oligonucleotides Integrated DNA technologies Inc
4.3. Common Procedures 
4.3.1. Agarose Gel Electrophoresis 
The DNA samples were mixed in a final concentration of 1X loading buffer 
[0.04% (w/v) bromophenol blue, 5% (v/v) glycerol], and ~4 µl of the mixture was loaded 
into the agarose gel.  The samples were resolved on the agarose gel at 120V for 12 min in 
1X TAE buffer (40 mM Tris-acetate, 1 mM EDTA pH 8.0), and visualized with a UV-
lamp at 365 nm.  The agarose gels consisted of 1.0% to 1.4% (w/v) agarose, 1X TAE 
buffer, and 0.5 µg/ml ethidium bromide. 
4.3.2. Colony PCR 
To ensure that the insert was successfully cloned into the plasmid, colony PCR 
was preformed on each single colony-forming unit (CFU) on the Lauria-Bertani (LB) 
agar plate that contained the appropriate antibiotic.  A sterile pipette tip was used for 
picking each CFU, and each CFU was resuspended in 6 µl of sterile double-distilled 
water.  Four microliters of the resuspended colony was added to the PCR mixture in a 25 
µl final reaction volume that consisted of 1 Unit Taq DNA Polymerase, 100 µM of each 
dNTP, 1X Thermo-Pol Reaction Buffer, 1 µM of each Nfor and Crev oligonucleotides 
(Table 4.2).  The insert was amplified in a PCR Thermocycler by using the following 
conditions: 94°C, 2 min; 30X [94°C, 45 sec; 55°C, 1 min; 72°C, 1 min]; 72°C, 10 min; 
and then held at 4°C.  The PCR products were visualized on a 1.5% agarose gel (section 
4.3.1), in order to determine if the size of the insert corresponded to the gene of interest. 
 
PCR Step Oligonucleotide 
Label 
Oligonucleotide Sequence (5'-3') Template 
1.     Nfor T7 Pro taa tac gac tca cta tag gg PET28a plasmid 
Crev T7 Ter gct agt tat tgc tca gcg g Containing 
    recA or lexA 
1.     Nfor ADH1 Pro (for) tat acc aag cat aca atc aac tcc pEG202 plasmid 
Crev ADH Ter (rev) ata aga aat tcg ccc gg Containing 
    lexA 
1.     Nfor GAL1 Pro (for) taa tac ttt caa cat ttt cg pJG4-5 plasmid 
Crev P2 RecA-XhoI (rev) ccg ctc gag tta aaa atc ttc gtt agt- Containing 
   ttc tgc recA 
Table 4.2.   Oligonucleotides used in detecting the recA insert in the pET28a 
and pJG4-5 plasmids, and lexA inserts in the pET28a and pEG202 plasmids. 
4.3.3. SDS-gel Electrophoresis 
Six microliters of the reaction was mixed in a final concentration of 1X Loading 
buffer [50 mM Tris-HCl pH 6.8, 1% (v/v) β-mercaptoethanol, 2% (w/v) SDS, 0.1% (w/v) 
bromophenol blue, 10% (v/v) glycerol].  The mixture was loaded into a SDS-
polyacrylamide gel and resolved at 200V for ~60 min.  The protein bands were visualized 
by staining the gel with Coomassie Brilliant Blue.  The resolving gel was composed of 
12% (w/v) acrylamide mix, 380 mM Tris-base pH 8.8, 0.1% (w/v) SDS, 0.1% (w/v) 
ammonium persulfate, and 0.04% (v/v) TEMED.  The stacking gel was composed of 5% 
(w/v) acrylamide mix, 130 mM Tris-HCl pH 6.8, 0.1% (w/v) SDS, 0.1% (w/v) 
ammonium persulfate, and 0.1% (v/v) TEMED. 
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4.3.4. Synthetic Media 
The following recipes for making the synthetic plates and liquid media in the 
yeast monohybrid system are described in Geyer and Brent (2000).  Synthetic plates and 
liquid media were prepared in a 1 L final volume as described below. 
 
 YPD plates and liquid media:
  
Yeast extract 10 g 
Peptone 20 g 
Agar (plates only) 20 g 
H2O 950 ml 
 
 
 
 
 
 
 
Autoclave YPD media for 20 minutes at 1.05 kg/cm2 and add 50 ml 40% (w/v) glucose. 
 
 Dropout plates and liquid media: 
  
Yeast nitrogen base without amino acids 6.7 g 
  
Dropout base x 
Agar (plates only) 20 g 
H2O:  
(glucose plates or media) 950 ml 
Or  
(galactose/saccharose plates or media) 925 ml 
 
 
 
 
 
 
 
 
 
 
 
 
Where x is equal to the amount of the appropriate CSM (complete supplement mixture) 
dropout base: 0.77 g CSM –TRP, 0.74 g CSM –HIS, 0.62 g CSM –HIS –LEU –TRP, or 
0.61 g CSM –ADE –HIS –LEU –TRP.  Autoclave media for 20 minutes at 1.05 kg/cm2 
and add either 50 ml of 40% (w/v) glucose (glu), or 50 ml of 40% (w/v) galactose (gal) 
and 25 ml of 40% (w/v) saccharose (sac). 
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 X-Gal plates:  
  
Yeast nitrogen base without amino acids 6.7 g 
Dropout base x 
Agar 20 g 
H2O:  
(glucose plates or media) 850 ml 
or  
(galactose/saccharose plates or media) 825 ml 
  
 
 
 
 
 
 
 
 
 
 
 
Where x is equal to the amount of the appropriate CSM dropout base: 0.74 g CSM –HIS, 
or 0.62 g CSM –HIS –LEU –TRP*.  Autoclave media for 20 minutes at 1.05 kg/cm2 and 
add either 50 ml of 40% (w/v) glu, or 50 ml of 40% (w/v) gal and 25 ml of 40% (w/v) 
sac.  Cool media to 55°C and add 10X BU salts (see below).  Add 4 ml of 5-bromo-4-
chloro-3-indolyl-β-D-galactopyranoside (X-Gal; 20 mg/ml dissolved in dimethyl 
formamide). 
 
 10X BU salts:   
Na2PO4 · 7H2O 70 g 
NaH2PO4 30 g 
H2O 900 ml 
 
 
 
 
 
Adjust 10X BU salts to pH 7.0 and autoclave BU salts for 20 minutes at 1.05 kg/cm2.  
4.4. The Yeast Monohybrid Screen for Hyper-active RecA Mutants 
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4.4.1. Site Directed Mutagenesis by Overlap Extension PCR of lexA 
Both lexA mutants, K156A and S119A were generated by site-directed 
mutagenesis by overlap extension PCR as described in Sambrook and Russell (2001b).  
Briefly, the overlap site in each 5’- and 3’-regions of the DNA fragments were generated 
from the template pEG202 vector with the Nfor/Nrev (Table 4.3; PCR step 1a) and Cfor/Crev 
(Table 4.3; PCR step 1b) oligonucleotide pairs respectively.  The conditions used in the 
first PCR step consisted of 94°C, 1 min; 30X [94°C, 45 sec; 55°C, 1 min; 72°C, 1 min]; 
72°C, 10 min; and then held at 4°C.  The mixture for the PCR reaction was made up to a 
 
* If the yeast cells were not transformed with the pJG4-5 vector, then the media was supplemented with 100 
mg TRP. 
50 µl reaction volume that consisted of 1 Unit PFU DNA Polymerase, 100 µM of each 
dNTP, 1X Thermo-Pol Reaction Buffer, 1 µM of each Nfor and Nrev, or Cfor and Crev 
oligonucleotides, and 500 ng pEG202 plasmid.  In all cases the two gene fragments were 
purified from a 1% agarose gel with the QIAquick Gel Extraction Kit unless otherwise 
stated. 
In the second PCR step, each 5’- and 3’-regions of the PCR fragments were fused 
together and amplified by the Nfor/Crev oligonucleotide pair (Table 4.3; PCR step 2), in 
order to generate the ORF of interest.  The conditions and composition of the mixture 
used in the second PCR step were similar to the first PCR step, except that the extension 
time at 72°C was 2 min, the template DNA consisted of 200 ng of each 5’- and 3’-regions 
of the DNA fragments, and the ORF was amplified with 1 µM of each Nfor and Crev 
oligonucleotides.  The resulting ORFs from the PCR were not purified in order to 
maximize the cloning of the ORF into pEG202 plasmid via homologous recombination in 
yeast (discussed later). 
4.4.2. Random Mutagenic PCR of recA 
The recA library was generated from the wild-type recA or recA E96D template 
by random mutagenic PCR with the Nfor/Crev oligonucleotide pair (Table 4.3; PCR step 
2).  The conditions and composition of the mixture used in PCR are described in section 
4.4.1, except that the extension time at 72°C was 2 min, 1 Unit Taq DNA Polymerase 
was used in the reaction mixture, and the template DNA consisted of 200 ng of wild-type 
recA or recA E96D.  The resulting ORFs from the PCR were not purified in order to 
maximize the cloning of the ORF into pJG4-5 plasmid via homologous recombination in 
the yeast cell (discussed later). 
 
PCR Step Construct Sequence (5'-3') Template 
  LexA K156A (Bait)     
1a. Nfor ADH1 Pro (for) tat acc aag cat aca atc aac tcc pEG202 
Nrev LexA K156A (rev) gaa gtt acc gtt gct cgc ctg aaa aaa cag g   
1b. Cfor LexA K156A (rev) cag gcg agc aac ggt aac ttc gtc atc pEG202 
Crev LexA XhoI  ADH  aat tcg ccc gga att agc ttg gct gca ggt cga-   
   Ter (rev) ctc gag tta cag cca gtc gcc gtt gc   
Table 4.3.   Oligonucleotides and templates that were used in generating lexA 
K156A and lexA S119A inserts, and recA library. 
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2.   Nfor ADH1 Pro (for) tat acc aag cat aca atc aac tcc 5'-lexA K156A
Crev LexA XhoI  ADH aat tcg ccc gga att agc ttg gct gca ggt cga- & 
   Ter (rev) ctc gag tta cag cca gtc gcc gtt gc 3'-lexA K156A
  LexA S119A (Bait)     
1a. Nfor ADH1 Pro (for) tat acc aag cat aca atc aac tcc pEG202 
Nrev LexA S119A (rev) cga tat ctt tca tcg cca tcc cgc tga cgc   
1b. Cfor LexA S119A (for) cgt cag cgg gat ggc gat gaa aga tat cgg pEG202 
Crev LexA xhoI  ADH Ter (rev) aat tcg ccc gga att agc ttg gct gca ggt cga-   
    ctc gag tta cag cca gtc gcc gtt gc   
2.   Nfor ADH1 Pro (for) tat acc aag cat aca atc aac tcc 5'-lexA S119A
Crev LexA XhoI  ADH Ter (rev) aat tcg ccc gga att agc ttg gct gca ggt cga- & 
    ctc gag tta cag cca gtc gcc gtt gc 3'-lexA S119A
  RecA library (Prey)     
1.   Nfor RecA pJG4-5 (for)- tac cct tat gat gtg cca gat tat gcc tct ccc- RecA E96D 
  EcoRI site gaa ttc atg gct atc gac gaa aac aaa c or 
Crev RecA pJG4-5 (rev)- XhoI site tga cca aac ctc tgg cga aga agt cca aag- wild-type recA
    ctt ctc gag tta aaa atc ttc gtt agt ttc   
 
4.4.3. Restriction Endonuclease Digest 
The appropriate plasmid for either lexA or recA ORFs (pEG202 or pJG4-5 
respectively) was digested for 15 hr at room temperature (20°C) with the appropriate 
restriction endonucleases.  The restriction digest for the pEG202 plasmid was made up to 
a 50 µl final reaction volume that consisted of 1.0 µg pEG202 plasmid, 25 Units EcoR I, 
25 Units BamH I, and 1X NEBuffer #2.  On the other hand, the restriction digest for the 
pJG4-5 plasmid was made up to a 50 µl final reaction volume that consisted of 1.0 µg 
pJG4-5 plasmid, 25 Units EcoR I, 25 Units XhoI, and 1X Buffer R+.  In all cases the 
digested products were purified from a 1% agarose gel (section 4.3.1) with the QIAquick 
Gel Extraction Kit unless otherwise stated. 
4.4.4. Yeast Transformation 
The procedures for transforming the yeast cells are described in the Lithium 
Acetate High Efficiency protocol (Schiestl and Gietz, 1989), which was used in three 
different situations.  (1) Cloning the insert (either recA library, lexA K156A, or lexA 
S119A) into the vector of interest via homologous recombination in S. cerevisiae strain 
EY93.  (2) Transforming the lexA K156A or lexA S119A pEG202 plasmid into S. 
cerevisiae strain EY111, which served as bait in screening for hyper-active RecA 
mutants.  (3) Transforming the isolated recA mutant pJG4-5 plasmid into S. cerevisiae 
strain EY111 that contained lexA K156A pEG202, such that the interaction between the 
bait and prey could be reconfirmed.  Briefly, the yeast cells were grown in 50 ml media* 
until an OD600nm of 0.6 to 0.8 was reached.  The culture was then harvested by 
centrifugation at 3,901 xg for 4 min at 10°C.  The cell pellet was resuspended with 100 
mM lithium acetate in a 1 ml final volume, and subsequently centrifuged at 15,700 xg for 
15 sec at 20°C.  The cell pellet was resuspended again with 100 mM lithium acetate in a 
500 µl final volume, then distributed into ten 50-µl aliquots (ten transformations), and 
centrifuged at 15,700 xg for 15 sec.  The supernatant was removed and the ingredients 
listed below were added to the cell pellet in the following order: 
 
50% (w/v) Polyethylene glycol 3500 240 µl
1 M Lithium acetate 36 µl
2 mg/ml ssDNA 25 µl
400 ng plasmid DNA 
or 
400 ng plasmid DNA + 800 ng insert 50 µl
 
 
 
 
 
 
The sample was mixed by vortexing until the pellet was completely resuspended.  The 
DNA of interest was transformed into the host cell by heat shock, where the mixture was 
incubated at 30°C for 30 min, and then heat shocked at 42°C for 20 min.  The sample was 
centrifuged at 5,900 xg for 15 sec, and the cell pellet was suspended in 500 µl of sterile 
double-distilled water.  The cell suspension was plated on the appropriate CSM dropout 
base media by using sterile glass beads, and then incubated at 30°C for 3 days.  The CSM 
dropout base media used for plating the transformants were: SD H- for yeast cells that 
contained the lexA K156A or lexA S119A pEG202 plasmid, SD W- for the yeast strain 
EY93 that contained the recA library pJG4-5 plasmid, and SD H- W- for the yeast strain 
EY111 that contained the recA mutant pJG4-5 plasmid and the lexA K156A pEG202 
plasmid. 
4.4.5. Yeast Minipreparation 
After cloning lexA K156A or lexA S119A into the pEG202 vector via homologous 
recombination, the lexA mutant plasmid was isolated as described in the Yeast 
 36
                                                 
* The media consisted of YPD for either EY111 or EY93 cells, and SD H- for EY111 cells that contained 
lexA K156A or lexA S119A pEG202 plasmid. 
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Minipreparation protocol (Geyer and Brent, 2000).  Briefly, several colonies were picked 
from the SD H- plates, and inoculated into 3 ml SD H- media.  [Also, a sample from a 
single colony that contained the recA library was picked from the master plate (section 
4.4.8.1) and then inoculated into 3 ml SD W- media].  The cells were grown overnight in 
a shaking incubator at 30°C, and on the following day the cells were harvested by 
centrifugation at 3,901 xg for 5 min.  The cell pellet was resuspended in 200 µl of 
breaking buffer [2% (v/v) Triton X-100, 1% (v/v) SDS, 100 mM NaCl, 10 mM Tris-HCl 
pH 8.0, 1 mM EDTA], and followed by the addition of ~300 µg of glass beads (425–600 
µm) and 200 µl of phenol-chloroform-isoamyl alcohol (25:24:1, v/v/v).  The cell walls 
were then disrupted by vortexing the mixture vigorously for 2 min.  One microliter of the 
aqueous mixture that contained the plasmid of interest was transformed into E. coli XL1 
Blue by electroporation (5 msec at 1,700 volts).  The transformants were incubated for 1 
hr at 37°C, and then plated on LB media that contained 100 µg/ml ampicillin (amp).  On 
the following day, the CFUs that contained the insert of interest was identified by Colony 
PCR (section 4.3.2), and subsequently inoculated in 5 ml LB media that contained 100 
µg/ml amp.  The cells were grown overnight in a shaking incubator at 37°C, and on the 
following day the plasmid DNA was extracted from the overnight culture with the 
QIAgen Miniprep Kit.  The isolated plasmid DNA was then sent for sequencing at the 
National Research Council (Saskatoon, SK). 
4.4.6. Harvesting and storing of the transformed Library 
Following transformation of the recA library into the yeast strain EY93 (section 
4.4.4), the cells were harvested and stored at –80°C as described in the Harvesting and 
Pooling Primary Transformants protocol (Serebriiskii et al., 2005).  Briefly, the CFUs on 
SD H- W- plates were suspended in sterile double-distilled water, and pooled in 50 ml 
falcon tubes.  The cell suspension was centrifuged at 3,901 xg for 5 min at 20°C, and 
then the pellet was resuspended in 1 volume of freeze down solution [65% glycerol, 0.1 
M MgSO4, 25 mM Tris-HCl pH 8.0].  Two hundred microliters of the cells were then 
dispensed into Eppendorf tubes, wrapped in wet towels, and stored at –80°C for 
subsequent use.  The titer of the frozen transformants was determined by plating serial 
dilutions on SD H- W- media.  The number of CFUs was then counted after 3 days of 
growth at 30°C (~108 cells/200 µl). 
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4.4.7. Mating S. cerevisiae Strains EY93 and EY111 
Mating between the haploid strain EY111 (that contained lexA K156A or S119A 
plasmid) and the haploid strain EY93 (that contained the recA library plasmid) was 
performed according to the Mating the Bait Strain and the Pre-transformed Library 
protocol (Serebriiskii et al., 2005).  Briefly, the haploid strain EY111 (that contained lexA 
K156A or S119A plasmid) was grown to an OD600 nm of 0.7 in 50 ml SD H- media (~10 
x108 cells), and then the cells were harvested by centrifugation at 3,082 xg for 5 min at 
20°C.  The cell pellet was resuspended with sterile double distilled water in a 1 ml final 
volume.  At the same time, the haploid strain EY93 (that contained the recA library 
plasmid) was thawed at 20°C.  The two strains, EY111 and EY93 were mixed together 
(bait/prey ratio of 2:1; x108 cells), plated on a single 100-mm diameter YPD media, and 
incubated overnight at 30°C.  On the following day, the CFUs on the YPD plates were 
suspended in sterile double-distilled water, pooled in a 50 ml falcon tube, and centrifuged 
at 3,082 xg for 5 min at 20°C. The cell pellet was resuspended with 1 volume of freeze 
down solution, then distributed in 200 µl aliquots, and stored at –80°C for future use.  
The titer for the frozen mated cells was determined by plating serial dilutions on SD H- 
W- media.  The number of colony forming units was counted after 3 days of growth at 
30°C (~0.5 x108 cells/200 µl). 
4.4.8. Screening for hyper-active RecA Mutants 
An aliquot of the mated cells was thawed at 20°C.  One hundred microliters of the 
thawed cells were inoculated into 10 ml gal/sac H- W- media, and incubated for ~4 hr in a 
shaking incubator at 30°C.  Due to the high level of background growth, only 106 cells* 
were plated on each five 100-mm diameter X-Gal gal/sac H- W- L- media.  The cells were 
grown for a maximum of 4 days at 30°C, and subsequently transferred and grouped on a 
SD H- W- master plate according to the day that they appeared. 
4.4.8.1. First Confirmation of the Positive Interactions 
The positive interactions from the master plate were first confirmed for the 
activation of the LEU2 and ADE2 reporter genes on gal/sac H- W- L- A- plates.  Also, the 
samples were checked for the repression of the LEU2 and ADE2 reporter genes on SD H- 
 
* The number of cells in the liquid media was determined by vis-spectroscopy where an OD600 nm of 1.0 ≈ 3 
x108 cells. 
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W- L- A- plates.  The latter test determined if the galactose inducible promoter in the 
pJG4-5 vector was repressed in the absence of galactose, and/or if there was 
contamination in the mated cells. 
4.4.8.2. Second Confirmation of Positive Interactions 
Following the first confirmation of the positive interactions, the samples were 
reconfirmed in the haploid strain EY111 that contained the lexA K156A plasmid.  The 
steps that are involved in the isolation of the plasmid from the positive interactions, 
purification of the plasmid, and transformation of the purified plasmid in the yeast strain 
EY111 (that contained the lexA K156A plasmid) are described in section 4.4.5.  Briefly, 
the CFUs from the master plate were inoculated into 3 ml SD W- media, and grown 
overnight at 30°C.  The plasmid DNA was extracted from the yeast culture, transformed 
into E. coli XL1 blue, and grown overnight in a shaking incubator at 37°C.  The plasmid 
was purified from the overnight cell culture, and then transformed into the haploid strain 
EY111 (that contained the lexA K156A plasmid) as described in section 4.4.4.  Ten 
colonies from each transformation were transferred onto a single SD H- W-master plate, 
and grown for 3 days at 30°C.  The samples from the master plate were transferred onto 
X-Gal gal/sac H- W- plates and grown for 3 days at 30°C, in order to test for the 
activation of the lacZ reporter gene.  The samples from the master plate were also 
transferred onto gal/sac H- W- L- A- plates and grown for 3 days at 30°C, in order to test 
for the activation of the LEU2 and ADE2 reporter genes. 
4.5. Analysis of the RecA/LexA Complex in vitro 
4.5.1. Site Directed Mutagenesis by Overlap Extension PCR 
The mutations identified from the yeast monohybrid screen were introduced into 
the wild-type recA or recA E96D gene by site-directed mutagenesis by overlap extension 
PCR as described in Sambrook and Russell (2001b), in order to  clone the mutants into 
the pET28a plasmid (discussed later).  Briefly, the overlap site in each 5’- and 3’-regions 
of the DNA fragments were generated from the wild-type recA or recA E96D gene with 
the Nfor/Nrev (Table 4.4; PCR step 1a) and Cfor/Crev (Table 4.4; PCR step 1b) 
oligonucleotide pairs respectively.  The conditions and composition of the mixture used 
in the PCR are described in section 4.4.1, except that the extension time at 72°C was 2 
min, and the template DNA consisted of 500 ng of recA or recA E96D. 
In the second PCR step, each 5’- and 3’-region of the DNA fragments were fused 
together and amplified by the Nfor/Crev oligonucleotide pair (Table 4.4; PCR step 2), in 
order to generate the ORF of interest.  The reaction conditions and composition of the 
mixture used in the second PCR step are described in section 4.4.1, except that the 
extension time at 72°C was 2 min and 20 sec.  In all cases the ORF products were 
purified with the QIAquick PCR Purification Kit unless otherwise stated. 
 
Table 4.4. The oligonucleotides used in generating the recA mutants. 
PCR Step Construct/ oligonucleotide Oligonucleotide sequence (5'-3') Template 
  RecA K216E     
1a. Nfor T7 Pro taa tac gac tca cta tag gg wild-type recA  
Nrev RecA K216E (rev) cag agg cgt aga att cca gcg cgt tac c   
1b. Cfor RecA K216E (for) ggt aac gcg ctg gaa ttc tac gcc tct g wild-type recA  
Crev T7 Ter gct agt tat tgc tca gcg g   
2.   Nfor T7 Pro taa tac gac tca cta tag gg 5'-recA K216E 
      & 
Crev T7 Ter gct agt tat tgc tca gcg g 3'-recA K216E 
  RecA E96D K216E     
1a. Nfor T7 Pro taa tac gac tca cta tag gg recA E96D 
Nrev RecA K216E (rev) cag agg cgt aga att cca gcg cgt tac c   
1b. Cfor RecA K216E (for) ggt aac gcg ctg gaa ttc tac gcc tct g recA E96D 
Crev T7 Ter gct agt tat tgc tca gcg g   
2.   Nfor T7 Pro taa tac gac tca cta tag gg 5'-recA E96D K216E 
      & 
Crev T7 Ter gct agt tat tgc tca gcg g 3'-recA E96D K216E 
  RecA K198N     
1a. Nfor T7 Pro taa tac gac tca cta tag gg wild-type recA 
Nrev RecA K198N (rev) cac acc aat att cat acg gat ctg   
1b. Cfor RecA K198N (for) gat ccg tat gaa tat tgg tgt gat g wild-type recA  
Crev T7 Ter gct agt tat tgc tca gcg g   
2.   Nfor T7 Pro taa tac gac tca cta tag gg 5'-recA K198N 
      & 
Crev T7 Ter gct agt tat tgc tca gcg g 3'-recA K198N 
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4.5.2. Molecular cloning and Transformation 
The ORF (insert) generated from section 4.5.1 was digested for 15 hr at 20°C 
with NcoI and XhoI restriction endonucleases.  The mixture was made up to a 50 µl final 
reaction volume that consisted of 2.0 µg insert (alternatively 1.0 µg pET28a), 25 Units 
NcoI, 25 Units XhoI, and 1X Buffer R+.  The purified insert was ligated into the pET28a 
vector at the NcoI and XhoI restriction sites (insert/vector ratio 3:1) for 15 hr at 20°C.  
The ligation mixture was made up to a 10 µl final reaction volume that consisted of 1X 
Ligation Buffer, 2 Units T4 DNA Ligase, ~20 ng of digested insert, and 2 ng of digested 
pET28a.  On the following day, the XL1 Blue cells were transformed with 1 µl of the 
ligation mixture by electroporation (5 msec at 1,700 volts), and then recovered in 1 ml 
LB media for one hour at 37°C.  Two hundred fifty microliters of the transformants were 
plated on LB media that contained 35 µg/ml kanamycin (kan) and grown overnight in a 
shaking incubator at 37ºC.  On the following day, the CFUs that contained the insert of 
interest were determined by colony PCR (section 4.3.2), inoculated into 10 ml LB media 
that contained 35 µg/ml kan, and grown overnight in a shaking incubator at 37°C.  The 
plasmid construct of interest was purified from the overnight culture with the QIAgen 
Miniprep Kit, and then sent for sequencing at the National Research Council (Saskatoon, 
SK). 
4.5.3. BL21 Culture and Gene Induction 
The plasmid construct of interest (lexA or recA) was transformed into E. coli 
BL21 (DE3) by electroporation (5 msec at 1,600 volts), and then recovered in 1 ml LB 
media for one hour at 37°C.  The transformants were inoculated into 10 ml LB media that 
contained 35 µg/ml kan and 0.3% (w/v) D-glucose, and grown overnight in a shaking 
incubator at 37ºC.  The overnight culture was then inoculated into 1 L LB media that 
contained 35 µg/ml kan, grown to an OD600 of ~0.6 at 37ºC, and then induced with 0.120 
mM isopropyl thio-β-D-galactoside (IPTG) for 3 hrs in a shaking incubator at 30ºC.  The 
culture was harvested by centrifugation at 4,648 xg for 15 min at 6ºC, and the cell pellet 
was stored at -20ºC for future use. 
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4.5.4. Cell lysis and Protein Purification 
4.5.4.1. LexA Protein 
The cell pellets that contained His-tagged LexA was thawed at 20°C and 
resuspended in ice-cold Binding buffer A (30 mM Tris-HCl pH 7.5, 0.5 M NaCl).  The 
cell suspension was homogenized on ice by sonication for five rounds (3” pulse, 6” rest; 
90” total) and then centrifuged at 21,289 xg for 30 min at 6ºC.  The DNA and cell debris 
was removed from the supernatant with the DE52 anion exchange column that was pre-
equilibrated with Binding buffer A.  The flow through from the anion exchange column 
was loaded onto the Ni-chelating Sepharose fast flow column that was pre-equilibrated 
with the Binding buffer A.  The Ni chelating column that contained the bound protein 
was washed with five column volumes of Wash buffer A*; and then stripped from the 
column with two column volumes of Elution buffer (30 mM Tris-HCl pH 7.5, 0.5 M 
NaCl, 300 mM imidazole).  Fractions with the highest protein yield were pooled together 
as determined by visualization on a 15% SDS-polyacrylamide gel that was stained with 
Coomassie Brilliant Blue (section 4.3.3). 
4.5.4.2. RecA Protein 
The purification of His-tagged RecA is described in section 4.5.4.1, except that 
Binding buffer A consisted of 30 mM Tris-HCl pH 7.9, 0.5 M NaCl.  Additionally, the 
bound protein in the Ni chelating column was washed with two column volumes of Wash 
buffer A1 (30 mM Tris-HCl pH 7.9, 0.5 M NaCl, 2 M Urea), followed by three column 
volumes of Wash buffer A2 (30 mM Tris-HCl pH 7.9, 0.5 M NaCl, 30 mM imidazole), 
and then stripped with two column voumes of Elution buffer (30 mM Tris-HCl pH 7.9, 
0.5 M NaCl, 300 mM imidazole). 
4.5.4.3. Thrombin cleavage 
The histag was removed from the protein of interest with 0.5 Unit/mg of thrombin 
(optional for the LexA samples).  The digestion for the RecA samples proceeded for 15 
hr at 4ºC, and the digestion for the LexA samples proceeded for 15 hr at 20°C.  The 
 
* The column was washed as needed, until the residual protein was no longer detected by the 1X Bradford 
reagent. 
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completeness of the digestion was determined by visualization on a 12% SDS-
polyacrylamide gel that was stained with Coomassie Brilliant Blue (section 4.3.3). 
4.5.4.4. Gel Filtration and Storage of Protein 
The protein sample was treated with 0.1% (v/v) β-mercaptoethanol and then 
precipitated with 35% (w/v) ammonium sulfate for at least 6 hrs at 4ºC.  The sample was 
then centrifuged at 28,977 xg for 20 min at 4ºC, and the protein pellet (~60 mg) was 
resuspended in 4 ml of running buffer.  (Trace amounts of protein that did not dissolve in 
the running buffer were removed by centrifugation at 15,700 xg for 1 min at 20°C.  The 
running buffer for LexA consisted of 30 mM Tris-HCl pH 7.5, 0.2 M NaCl, and 0.1% 
(v/v) β-mercaptoethanol.  On the other hand, the running buffer for RecA consisted of 30 
mM Tris-HCl pH 7.9, 2.0 M NaCl, 2.0 M Urea, and 0.1% (v/v) β-mercaptoethanol. 
The LexA and RecA samples were loaded onto a Äkta Prime Protein Purification 
System, and resolved on a HiPrep Sephacryl S-100 and S-300 HR columns (Amersham 
Biosciences) respectively at a flow rate of 1.0 ml/min.  The fractions for the second peak 
of the LexA sample (dimer form) and the third peak of the RecA sample (hexamer form) 
were collected and pooled.  The pooled samples were concentrated with an Amicon 
Ultra-4 centrifugal filter device (10,000 nominal Molecular Weight Limit; Millipore) at 
3,901 xg, until a final concentration in the range of 16-25 mg/ml was reached.  (The 
concentration of the samples was determined with a 1X Bradford Reagent at 595 nm).  
The samples were then quench-frozen with liquid nitrogen in a 500 µl PCR tube, and 
stored at –79ºC for subsequent use.  A cryoprotectant [20% (w/v) sucrose] was also 
added to the RecA samples, in order to protect the protein against aggregation during the 
freezing and storing process (Cleland et al., 2000). 
4.5.5. ATPase Assay 
The Malachite Green reagent used in the ATPase assay was prepared by mixing 
10 ml of solution A [0.045% (w/v) Malachite Green oxalate] with 30 ml of solution B 
[4.2% (w/v) ammonium molybdate, 4 N HCl], and letting it sit for 30 min at 4ºC.  Forty 
microlitres of the enzymatic reaction was added to the Malachite Green reagent in a 1 ml 
final reaction volume, and then developed for 1 min before measuring the OD at 620 nm 
for the amount of inorganic phosphate released in 30 min.  The mixture for the enzymatic 
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reaction consisted of 150 mM MES [2-(4-morpholino)-ethane sulfonic acid] pH 6.9, 8 
mM MgCl2, 5 mM ATP, 15% (w/v) PEG 400, 10 µM RecA sample, and 40 µM LexA 
sample.  All of the enzymatic reactions were incubated for 30 min at 37ºC, before mixing 
the samples with the Malachite Green reagent.  The PEG gradient mixture was also 
similar, except that the PEG concentration varied from 0 to 15% (w/v) and NaCl 
concentrations remained constant at 0.2 M. 
The standard, NaH2PO4 was used to determine the amount of inorganic phosphate 
(Pi) released during the enzymatic reaction.  The calibration curve was constructed in the 
range of 0-1.0 mM NaH2PO4, where 40 µl of each standard was added to the Malachite 
Green reagent in a 1 ml final reaction volume.  Each standard was developed for 1 min 
before measuring the OD at 620 nm. 
4.5.6. Coprotease Assay 
The reaction mixture for the coprotease assay was made up to a 20 µl final 
reaction volume that consisted of 150 mM HEPES pH 7.5, 8 mM MgCl2, 15% (w/v) PEG 
400, 1.5 mM ATP substrate (ATP, ATP-γ-S, or AMP-PNP), 10 µM RecA sample, and 40 
µM His-tagged wild-type LexA.  Also, RecA’s coprotease activity was further stimulated 
with the addition of 15 µM dT36 oligonucleotide.  The enzymatic reactions were 
incubated for 1 hr at 20°C, and stopped with 5 µl of 2X Loading buffer [100 mM Tris-
HCl pH 6.8, 2% (v/v) β-mercaptoethanol, 4% (w/v) SDS, 0.2% (w/v) bromophenol blue, 
20% (v/v) glycerol].  Six microlitres of this mixture was resolved on a 12% SDS-
polyacrylamide gel and then stained with Coomassie Brilliant Blue (section 4.3.3), in 
order to visualize the resulting cleavage products of the LexA repressor.  The PEG 
gradient mixture was also similar, except that the PEG concentration varied from 0 to 
18% (w/v), and the ATP substrate consisted of 1.5 mM ATP-γ-S. 
4.5.7. Inhibition Assay 
The reaction mixture for the inhibition assay was made up to a 20 µl final reaction 
volume that consisted of 150 mM HEPES pH 7.5, 8 mM MgCl2, 15% (w/v) PEG 400, 
and 1.5 mM ATP-γ-S substrate, 5 µM RecA sample, 40 µM His-tagged wild-type LexA, 
and 10 µM LexA inhibitor (K156A, or K156A dimer interface mutants).  The enzymatic 
reactions were incubated for 1 hr at 20°C, and stopped with 5 µl of 2X Loading buffer.  
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Six microlitres of this mixture was resolved on a 12% SDS-polyacrylamide gel and then 
stained with Coomassie Brilliant Blue (section 4.3.3) in order to visualize the resulting 
cleavage products of the LexA repressor. 
4.6. The Yeast Monohybrid Analysis of the LexA Dimer Interface Mutants 
4.6.1. Constructing the lexA Dimer Interface Mutants by PCR 
Before introducing the mutations at the dimer interface of lexA, the lexA b42AD 
fusion gene was constructed by overlap extension PCR.  In the first PCR step, the wild-
type lexA gene was amplified from the pEG202 plasmid with the Nfor/Nrev 
oligonucleotide pair (Table 4.5; PCR step 1a), while the b42AD gene was amplified from 
the pJG4-5 plasmid with the Cfor/Crev oligonucleotide pair (Table 4.51b).  The reaction 
conditions and composition of the mixture used in the first PCR step are described in 
section 4.4.1, except that the extension time at 72°C was 1 min, and the template DNA 
consisted of 250 ng of either pEG202 or pJG4-5 plasmid. 
In the second PCR step, the 5’-region of the lexA gene was fused to the 3’-region 
of the b42AD gene, and amplified with the Nfor/Crev oligonucleotide pair (Table 4.5; PCR 
step 2), in order to generate the lexA b42AD fusion gene.  The reaction conditions and 
composition of the mixture used in the second PCR step are described in section 4.4.1. 
The lexA b42AD fusion gene was then used as a template to generate the 
mutations at the dimer interface of lexA by site-directed mutagenesis by overlap 
extension PCR as described in Sambrook and Russell (2001b).  Briefly, the overlap site 
in the 5’-region of the lexA mutant fragment and 3’-region of the lexA mutant b42AD 
fragment were generated from the same lexA b42AD template with the Nfor/Nrev (Table 
4.5; PCR step 1a) and Cfor/Crev (Table 4.5; PCR step 1b) oligonucleotide pairs 
respectively.  The reaction conditions and composition of the mixture used in the PCR 
are described section 4.4.1, except that the extension time at 72°C was 2 min, and the 
template DNA consisted of 250 ng of the lexA mutant b42AD fragment. 
In the second PCR step, the 5’- and the 3’-regions of the DNA fragments were 
fused together and amplified with the Nfor/Crev oligonucleotides pair (Table 4.5; PCR step 
2), which generated the lexA dimer interface mutant b42AD gene.  The reaction 
conditions and composition of the mixture used in the second PCR step are described in 
section 4.4.1. 
 
PCR Step Construct Sequence (5'-3') Template 
 LexA B42AD   
1a. Nfor ADH1Pro (for) tat acc aag cat aca atc aac tcc pEG202 
Nrev ADH1T (rev) ata aga aat tcg ccc gga a  
1b. Cfor B42 Recomb P1 ggc gac tgg ctg gaa ttc atc aat aaa gat- 
atc- gag ga 
pJG4-5 
Crev B42 Recomb P2 agg tcg act cga gtt agg gag agg cat aat-
ctg- gca 
 
2.   Nfor P1 pEG202 amp gct tca cca ttg aag ggc tgg cgg ttg ggg 
tta- ttc gca acg gcg act ggc tgg aat tc 
LexA 
& 
Crev ADH1T (rev) ata aga aat tcg ccc gga a b42AD insert 
  LexA V100D B42AD   
1a. Nfor ADH1Pro (for) tat acc aag cat aca atc aac tcc lexA b42AD 
Nrev LexA V100D (rev2) gaa taa gga agg atc atc ctg ata atg acc- 
ttc 
 
1b. Cfor LexA V100D (for) gaa ggt cat tat cag gat gat cct tcc tta tt-
c aag 
lexA b42AD 
Crev ADH1T (rev) ata aga aat tcg ccc gga a  
2.   Nfor ADH1Pro (for) tat acc aag cat aca atc aac tcc 5'-lexA V100D & 
Crev ADH1T (rev) ata aga aat tcg ccc gga a 3'-lexA V100D b42AD 
  LexA V100K B42AD   
1a. Nfor ADH1Pro (for) tat acc aag cat aca atc aac tcc lexA b42AD 
Nrev LexA V100K (rev) gga agg atc ttt ctg ata atg acc ttc  
1b. Cfor LexA V100K (for) gaa ggt cat tat cag aaa gat cct tcc tta tt-
c aag 
lexA b42AD 
Crev ADH1T (rev) ata aga aat tcg ccc gga a  
2.   Nfor ADH1Pro (for) tat acc aag cat aca atc aac tcc 5'-lexA V100K & 
Crev ADH1T (rev) ata aga aat tcg ccc gga a 3'-lexA V100K b42AD 
  LexA I196D B42AD   
1a. Nfor ADH1Pro (for) tat acc aag cat aca atc aac tcc lexA b42AD 
Nrev LexA I196D (rev) cca gtc gcc gtt gcg atc aac ccc aac cgc-
cag 
 
1b. Cfor LexA I196D (for) ctg gcg gtt ggg gtt gat cgc aac ggc gac-
tgg 
lexA b42AD 
Crev ADH1T (rev) ata aga aat tcg ccc gga a  
2.   Nfor ADH1Pro (for) tat acc aag cat aca atc aac tcc 5'-lexA I196D & 
Crev ADH1T (rev) ata aga aat tcg ccc gga a 3'-lexA I196D b42AD 
Table 4.5.   The oligonucleotides used in generating the fusion gene and interface 
mutants for the yeast monohybrid system. 
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  LexA I196K B42AD   
1a. Nfor ADH1Pro (for) tat acc aag cat aca atc aac tcc lexA b42AD 
Nrev LexA I196K (rev) gtc gcc gtt gcg ttt aac ccc aac cgc cag-c  
1b. Cfor LexA I196K (for) cgg ttg ggg tta aac gca acg gcg act gg lexA b42AD 
Crev ADH1T (rev) ata aga aat tcg ccc gga a  
2.   Nfor ADH1Pro (for) tat acc aag cat aca atc aac tcc 5'-lexA I196K & 
Crev ADH1T (rev) ata aga aat tcg ccc gga a 3'-lexA I196K b42AD 
 
4.6.2. Cloning Insert and transforming Plasmid into Yeast Cells 
Both the lexA b42AD fusion and lexA dimer interface mutant b42AD genes were 
cloned into the backbone of the pEG202 vector via homologous recombination as 
described in section 4.4.4.  The transformants were plated on SD H- media and incubated 
for 3 days at 30°C.  On the following day, several CFUs were picked from the SD H- 
plates, inoculated into 3 ml SD H- media, and grown overnight in a shaking incubator at 
30°C.  The steps that are involved in the isolation of the plasmid that contained the gene 
of interest from the yeast cells, transformation of the plasmid into XL1 blue cells by 
electroporation, and purification of the plasmid from the overnight cell culture are 
described in section 4.4.5.  The purified plasmid was transformed into S. cerevisiae strain 
EY111 as described in section 4.4.4.  Several transformants were then plated into SD H- 
media and grown for 3 days at 30°C. 
4.6.3. Activation of Reporter Genes 
A single colony was picked from the SD H- plates, inoculated into 3 ml SD H- 
media, and grown overnight in a shaking incubator at 30°C.  The overnight cell culture 
was standardized to an OD 600 nm of 0.2 in 3 ml SD H- media, and subsequently grown to 
OD 600 nm of 0.8 in a shaking incubator at 30°C.  Serial dilutions were performed on the 
standardized cell culture in the range of 10-1 to 10-4-fold.  Two microliters from each 
dilution was plated onto both X-Gal SD H-, and X-Gal SD H- L- media; and grown for 3 
days at 30°C. 
4.7. Analysis of the LexA Dimer Interface Mutants in vitro 
The procedures for isolating the LexA mutant proteins and testing for their ability 
to inhibit RecA-mediated cleavage of wild-type LexA in vitro are described in section 
4.5, unless otherwise stated. 
4.7.1. Site Directed Mutagenesis 
The lexA dimer interface mutants were generated by site directed mutagenesis by 
overlap extension PCR as described in Sambrook and Russell (2001b).  Briefly, the 
overlap site in the 5’- and 3’-region of the lexA mutant fragments were generated from 
the ∆69lexA K156A template with the Nfor/Nrev (Table 4.6; PCR step 1a) and Cfor/Crev 
(Table 4.6; PCR step 1b) oligonucleotide pairs respectively.  The reaction conditions and 
composition of the mixture used in the PCR are described in section 4.4.1, except that the 
extension time at 72°C was 1 min and 20 sec, and the template DNA consisted of 250 ng 
of ∆69lexA K156A gene. 
In the second PCR step, the 5’- and the 3’-region of the lexA mutant fragments 
were fused together and amplified with the Nfor/Crev oligonucleotides pair (Table 4.6; 
PCR step 2), which generated the lexA dimer interface mutant gene.  The reaction 
conditions and composition of the mixture used in the second PCR step are described in 
section 4.4.1. 
Table 4.6.   Oligonucleotides used in generating the lexA dimer interface mutants. 
PCR Step Construct PCR Step Made by/Template 
  ∆69LexA K156A I196D  I. Moya 
1a. Nfor T7Pro (for) taa tac gac tca cta tag gg ∆69LexA K156A/ 
Nrev LexA I196D (rev) cca gtc gcc gtt gcg atc aac ccc- aac-
cgc cag 
 
1b. Cfor LexA I196D (for) ctg gcg gtt ggg gtt gat cgc aac- ggc-
gac tgg 
∆69LexA K156A 
Crev T7Ter (rev) gct agt tat tgc tca gcg g  
2. Nfor T7Pro (for) taa tac gac tca cta tag gg 5'-lexA K156A I196D 
& 
Crev T7Ter (rev) gct agt tat tgc tca gcg g 3'-lexA K156A I196D
  ∆ 69LexA K156A I196K  G. Qian 
1. Nfor T7Pro (for) taa tac gac tca cta tag gg ∆69lexA K156A 
Nrev P2 LexA I196K (rev) gtc gcc gtt gcg ttt aac ccc aac- cgc- 
cag c 
 
2. Cfor P3 LexA I196K (for) cgg ttg ggg tta aac gca acg gc-g act-
gg 
∆69lexA K156A 
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Crev P2-LexA Xho1 (rev) ccg ctc gag tta cag cca gtc gcc- gtt- 
gc 
 
2. Nfor T7Pro (for) taa tac gac tca cta tag gg 5'-lexA K156A I196K 
& 
Crev P2-LexA Xho1 (rev) ccg ctc gag tta cag cca gtc gcc- gtt- 
gc 
3'-lexA K156A I196K
  ∆ 69LexA K156A V100D  I. Moya 
1. Nfor T7Pro (for) taa tac gac tca cta tag gg ∆69lexA K156A 
Nrev LexA V100D (rev2) gaa taa gga agg atc atc ctg ata- atg- 
acc ttc 
 
2. Cfor LexA V100D (for) gaa ggt cat tat cag gat gat cct- tcc- 
tta ttc aag 
∆69lexA K156A 
    Crev T7Ter (rev) gct agt tat tgc tca gcg g  
2. Nfor T7Pro (for) taa tac gac tca cta tag gg 5'-lexA K156A V100D 
& 
Crev T7Ter (rev) gct agt tat tgc tca gcg g 3'-lexA K156A V100D
  ∆ 69LexA K156A V100K  G. Qian 
1. Nfor T7Pro (for) taa tac gac tca cta tag gg ∆69lexA K156A 
Nrev LexA V100K (rev) gga agg atc ttt ctg ata atg acc- ttc  
2. Cfor LexA V100K (for) gaa ggt cat tat cag aaa gat cct- tcc-
tta ttc aag 
∆69lexA K156A 
Crev P2-LexA Xho1 (rev) ccg ctc gag tta cag cca gtc gcc- gtt- 
gc 
 
2. Nfor T7Pro (for) taa tac gac tca cta tag gg 5'-lexA K156A V100K 
& 
Crev P2-LexA Xho1 (rev) ccg ctc gag tta cag cca gtc gcc- gtt- 
gc 
3'-lexA K156A V100K
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5. RESULTS 
5.1. Stimulation of RecA’s Activity by Polyethylene Glycol  
In previous studies, volume-excluding agents such as polyethylene glycol and 
polyvinyl alcohol have been shown to enhance RecA’s binding affinity for ssDNA and 
filament formation (Lavery and Kowalczykowski, 1992).  The volume-excluding agents 
exert their effect by reducing the energy barrier required to displace water between 
interacting molecules, thereby “squishing” them together (Zimmerman and Minton, 
1993).  A similar approach was taken in this study in order to reduce the energy barrier 
involved in the binding between RecA and the LexA repressor. 
Specifically, enhancement of RecA’s binding affinity for LexA K156A was 
examined with increasing concentrations of polyethylene glycol 400 (PEG 400)* in vitro.  
This was determined by measuring the level of RecA’s ATPase activity.  The rational 
behind this assay was based on the correlation between the level of RecA’s ATPase 
activity (i.e. active form of RecA) and the extension of its helical pitch upon binding of 
its substrate such as salt, ssDNA, or the LexA repressor (DiCapua et al., 1990a).  To 
determine whether RecA’s conformation had shifted towards the active form, the amount 
of inorganic phosphate (Pi) released during ATP hydrolysis was detected with a 
Malachite Green reagent at 620 nm.  This assay also served as an indicator for detecting 
the formation of the RecA/LexA complex, since previous studies had shown that RecA’s 
conformation in the presence of ssDNA was shifted towards the active form upon binding 
to the LexA protein (DiCapua et al., 1990a).  Additionally, 4-fold excess of the LexA 
protein was used throughout this experiment (the ATPase assay) and coprotease assay,** 
since it was the minimum concentration of protein that was required to saturate RecA’s 
ATPase and coprotease activities. 
 
*The volume-excluding agent, PEG 400 was selected for its low molecular weight since it did not affect the 
resolution of SDS-polyacrylamide gel when examining RecA’s coprotease activity. 
**Increasing concentrations of PEG did not facilitate the LexA protein to hydrolyze ATP during the ATPase 
assay, nor did it facilitate the cleavage of the LexA protein during the coprotease assay. 
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In the ATPase assay for wild-type RecA in the presence of ∆69LexA K156A, there 
was a 6-fold increase in the amount of Pi released as the PEG 400 concentration increased 
from 0% to 15% (w/v; Figure 5.1a)*.  One-third of this activity might be caused by an 
increase in self-polymerization of the RecA monomers as a result of dehydration (when 
examining RecA alone; Figure 5.1a) as proposed by Lavery and Kowalczykowski (1992).  
The remaining two-thirds of this activity was likely caused by an increase formation of 
the RecA/LexA complex as a result of dehydration at RecA’s binding site when RecA 
and ∆69LexA K156A were squished together (compare the difference between RecA in 
the presence and absence of LexA; Figure 5.1a).  Thus, a volume-excluding agent, PEG 
400 was able to enhance RecA’s binding affinity for the ∆69LexA K156A. 
The effect of increasing PEG concentrations on RecA’s coprotease activity was 
also tested in vitro, in order to detect the enhancement of RecA’s binding affinity for the 
LexA repressor.  Again the rational behind this assay is based on the correlation between 
the level of RecA’s coprotease activity and the extension of its helical pitch upon binding 
to the substrate.  The level of RecA’s coprotease activity was determined by the amount 
of His-tagged wild-type LexA cleavage products generated, as visualized on a 15% SDS 
polyacrylamide gel that was stained with Coomassie Brilliant Blue. 
In the coprotease assay, the level of RecA’s coprotease activity was found to 
increase as the concentration of PEG increased from 0% to 15% (w/v; Figure 5.1b).  
Beyond 15% (w/v) PEG 400, the level of RecA’s coprotease activity decreased, which 
might be attributed to the precipitation of RecA in the PEG 400 solution.  Thus, the 
volume-excluding agent was most effective at a 15% (w/v) in order to enhance RecA’s 
binding affinity for the LexA repressor. 
In general, RecA’s ATPase and coprotease activity did not require preactivation 
by ssDNA in vitro.  The addition of a volume-excluding agent and the LexA substrate  
 
 
*In the ATPase assay, PEG 400 concentrations greater than 15% (w/v) were not examined because RecA 
precipitates out of the solution.  Consequently, precipitation during crystallization trials was expected to 
reduce the quality of the crystal. 
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Figure 5.1. The effects of the increasing concentrations of PEG 400 on the
ATPase and coprotease activity of wild-type RecA. 
(a) The effect of increasing PEG 400 concentrations on the ATPase activity of 
wild-type RecA (10 µM) in the absence (●) and presence (■) of ∆69LexA K156A 
(40 µM).  The enzyme solutions contained 150 mM MES/NaOH pH 6.9 and 5 
mM ATP, and were incubated for 30 min at 37°C.  The amount of Pi released in 
30 min was detected with a Malachite Green reagent at 620 nm, and the mean 
±S.D was determined from two independent experiments.  (b) The effect of 
increasing PEG 400 concentrations on wild-type RecA (10 µM) mediated 
cleavage of His-tagged wild-type LexA (40 µM).  The enzyme solutions 
contained 150 mM HEPES/NaOH pH 7.5 and 1.5 mM ATP-γ-S, and were 
incubated for 1 hr at 20°C.  The control experiment was the same as above, except 
that the solution lacked both PEG and ATP-γ-S.  The reaction mixtures were 
resolved on a 15% SDS-polyacrylamide gel, and stained with Coomassie Brilliant 
Blue.  RecA-mediated cleavage of His-tagged wild-type LexA produced a N-
terminal fragment (histag-LexA1-84) and a C-terminal fragment (LexA85-202). 
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was able to activate RecA’s enzymatic activities and enhance the stability of the 
RecA/LexA complex.  These preliminary results led to the hypothesis that the formation 
of a RecA/LexA complex is a thermodynamic process that involves three steps.  To 
confirm the first two steps (i.e. the active form of RecA and cleavable form of LexA), the 
effects of a hyper-active RecA mutant and a LexA K156A mutant on RecA’s enzymatic 
activities were tested.  These mutants are expected to enhance the stability of the 
RecA/LexA complex, because they are known to have a reduced energy barrier for their 
conformational change. 
5.2. Isolating Hyper-active RecA Mutants 
Based on the thermodynamic model, one approach to enhance the stability of the 
RecA/LexA complex was to shift the conformation of RecA towards the active form.  For 
example, enhancement of the RecA/LexA complex was achieved by promoting RecA’s 
hyper-activity with the E96D and F217Y mutants, which were situated at RecA’s ATP 
binding core.  However, these mutants were not sufficient to enhance the stability of the 
RecA/LexA complex, such that it was able to utilize a non-hydrolysable AMP-PNP 
substrate during crystallization trials.  Therefore, the hyper-active RecA mutants were 
isolated from the yeast two-hybrid system, in order to further enhance the stability of the 
RecA/LexA complex. 
The hyper-active RecA mutants were generated from the wild-type recA and recA 
E96D templates by random mutagenic PCR.  The recA samples were cloned into the 
pJG4-5 vector via homologous recombination in the S. cerevisiae strain EY93 (prey 
strain), which created a library size of 4 x106 transformants.  The recA gene was cloned 
down stream from the b42 activation domain (b42AD).  This b42AD recA fusion 
construct was under the control of the GAL1 promoter (Figure 5.2a).  The lexA K156A 
and lexA S119A genes were cloned into the backbone of a pEG202 vector via 
homologous recombination in S. cerevisiae strain EY93, and these genes were 
constitutively expressed under the ADH1 promoter in S. cerevisiae strain EY111 (bait 
strain) (Figure 5.2b).  The non-cleavable LexA mutants, K156A and LexA S119A were 
chosen for this study because they do not undergo self-cleavage during the selection of a 
stable RecA/LexA complex.  Additionally, the LexA mutants are expected to moderate 
the stringency (i.e. RecA’s binding affinity for LexA) in the yeast two-hybrid system.  
For example, LexA S119A is expected to select for RecA mutants that have a very tight 
binding affinity, because RecA must overcome the energy barrier that is associated with 
the burial and deprotonation of ε-amino group of the K156 residue in LexA (Lin and 
Little, 1989; Luo et al., 2001).  On the other hand, this energy barrier is reduced in LexA 
K156A; therefore, the bait is expected to select for RecA mutants that have a weak 
binding affinity.  This latter situation is avoided by using a more stringent reporter gene 
(e.g. ADE2 or lacZ) since it contains more lexA operator sites (Estojak et al., 1995) or by 
increasing the number of reporter genes that are activated (e.g. LEU2 and ADE2) 
(Sambrook and Russell, 2001a).  Finally, it is noteworthy to point out that the LexA 
mutants are not a “hybrid” (fusion) protein, but the interaction trap still has the same 
underlying principles as a traditional yeast two-hybrid system (i.e. a prey and a bait 
protein).  
 
a. 
 
 
b. 
Figure 5.2.   A linear plasmid drawing for the recA library, lexA S119A,
and lexA K156A constructs. 
(a) The recA library was under control of the inducible GAL1 promoter.  
(b) The lexA S119A and lexA K156A gene were constitutively expressed 
under the ADH1 promoter. 
The prey strain that contained the recA library was mated with S. cerevisiae strain 
EY111 (bait strain) that contained either lexA K156A or S119A plasmid (Figure 5.3).  
However, the bait strain that contained the lexA K156A plasmid was used in the 
screening process, because there was an 8-fold increase in the number of interactions 
 54
obtained on X-Gal gal/sac H- W- L- plates when compared to the bait strain that contained 
the lexA S119A plasmid.  The activation of the lacZ reporter gene was also used in the 
screening process, because it was easier to distinguish between the background growth* 
and true positives. 
 
 
Figure 5.3.   A Flow chart for isolating the hyper-active-RecA 
mutants from the yeast monohybrid screen. 
 
In order to reconfirm the interactions from the yeast two-hybrid screen, the recA 
mutants were isolated and then transformed into the bait strain that contained LexA 
K156A.  The binding affinity between the RecA mutant and LexA K156A was 
determined by their ability to activate the lacZ reporter gene or both the LEU2 and ADE2 
reporter genes.  The activation of the lacZ reporter gene was detected on X-Gal gal/sac H- 
W- plates, such that a blue phenotype served as an indicator for a strong-binding affinity, 
while a white phenotype served as an indicator for a weak-binding affinity between the 
RecA mutant and LexA K156A.  The activation of both LEU2 and ADE2 reporter genes 
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* Background growth was observed on the control plates (SD H- W- L- A- media).  These cells were found 
to carry the recA and lexA K156A plasmid, which suggested that the GAL1 promoter for the prey plasmid 
was leaky. 
was detected on gal/sac H- W- L- A- plates, which provided three different roles in the 
analysis.  First, activation of the LEU2 reporter gene allowed the cells to grow on L- 
media.  Second, activation of the ADE2 reporter gene provided a white/red phenotype, 
such that a white phenotype served as an indicator for a strong-binding affinity, while a 
red phenotype served as an indicator for a weak-binding affinity between the RecA 
mutant and LexA K156A.  Third, the activation of both LEU2 and ADE2 reporter genes 
was a more stringent selection method than activating a single reporter gene. 
In this assay, the RecA mutants were able to activate either the lacZ, or both the 
LEU2 and ADE2 reporter genes on the X-Gal containing plates (Figure 5.4a) or L- A- 
plates (Figure 5.4b) respectively.  The samples were then sequenced (National Research 
Council) in order to identify the mutations responsible for shifting RecA’s conformation 
towards the active form.  Most of the mutations within the recA library were found to 
occur at the monomer-monomer interface of RecA, such as E63G, K216E/I, E127Y,  
 
            
Figure 5.4.   Reconfirming the isolated
cerevisiae strain EY111 that contained L
Saccharomyces cerevisiae strain EY111
the RecA mutants were grown on (a) X
H- W- L- A- plates for 4 days at 30°C
K156A, while the E96D cells contained
 56b.a.         
 hyper-active RecA mutants in S. 
exA K156A. 
 that contained both LexA K156A and 
-Gal gal/sac H- W- plates or (b) gal/sac 
.  The control cells contained LexA 
 both LexA K156A and RecA E96D. 
Q118R, A219V and D112G (Table 5.1).  Interestingly, the monomer-monomer interface 
mutant, K216E was a reoccurring mutation (5 out of 13 samples sequenced) and was 
generated from the E96D template.  On the other hand, the K198N mutation was the only 
sample that was not generated from the recA E96D template (Table 5.1) but still capable 
of activating the reporter genes.  Thus, RecA K216E and RecA K198N appeared to be 
good candidates for enhancing the stability of the RecA/LexA complex.  Therefore, the 
recA mutants were cloned into the pET28a vector, such that the protein could be purified 
from BL21 cells, and examined for their hyper-activity in vitro by using the ATPase and 
coprotease assay (discussed later). 
Table 5.1.   DNA sequencing results for the recA samples that were reconfirmed in 
the yeast two-hybrid system. 
Sample Mutation Sample Mutation Sample Mutation Sample Mutation
K3-1 E96D K216E K3-8 
E96D 
E127Y 
K216E D2-1 
E63G 
E96D 
R176H 
E235G 
K3-19 K198N A219V 
K3-2 
E96D 
Q124R 
K216E 
D2-2 E96D R169P 
K3-14 
E96D 
A147Y 
K216E 
K3-3 E96D K216I 
D3-A E96D M164T 
D3-4 
E96D 
K216E 
E296G 
K3-4 
E96D 
M175T 
G211D 
K3-15 
E96D 
Q118R 
E156G 
F191S 
K3-21 
E96D 
F191E 
I195T 
A214G 
 
5.3. Stimulation of RecA’s Activity by Other Substrates 
In this section, various substrates were examined for their effect on the stability of 
the RecA/LexA complex.  These include the effects of salt and ATP substrates in shifting 
RecA’s conformation towards the active form, the effect of a hyper-active RecA mutant 
in preactivating RecA, and the effect of LexA K156A (the cleavable form) in promoting 
RecA’s binding affinity.  All of these substrates are expected to reduce the energy barrier 
that is associated at each step in the thermodynamic process, thereby enhancing the 
stability of the RecA/LexA complex and providing evidence for the thermodynamic 
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model.  These effects were determined by measuring the level of RecA’s ATPase and 
coprotease activity (discussed below). 
Studies had shown that salt concentrations greater than 1.0 M were able to 
stimulate the ATPase activity of RecA in the absence of DNA, since the anions were 
believed to mimic the phosphate backbone of DNA (DiCapua et al., 1990a; Pugh and 
Cox, 1988).  A similar approach was taken in this study in order to determine the optimal 
salt concentration for a stabile RecA/LexA complex in a 15% (w/v) PEG 400 solution.  
These effects were monitored by measuring the level of RecA’s ATPase activity in a 
Malachite Green reagent at 620 nm.  The RecA proteins selected for this ATPase assay 
were wild type, K198N and K216E.  The latter two mutants were selected because the 
results from the yeast two-hybrid screen suggested that these mutants might have a 
greater binding affinity for the LexA repressor.  Additionally, the solutions were 
supplemented with either LexA S119A or K156A mutant* in order to examine RecA’s 
binding affinity for each mutant. 
The stability of the RecA/LexA complex was also reexamined with the coprotease 
assay at low salt concentrations.  This assay semi-quantifies the level of RecA’s 
coprotease activity (i.e. its mediated cleavage of the LexA repressor) by the amount of 
LexA cleavage products produced,  as visualized on a 15% SDS-polyacrylamide gel that 
was stained with Coomassie Brilliant Blue.  For example, high amounts of LexA 
cleavage products indicates that RecA has a tight-binding affinity for the LexA repressor; 
and therefore, a more stable RecA/LexA complex has formed.  On the other hand, low 
amounts of cleavage products indicates that RecA has a weak-binding affinity for the 
LexA repressor; and therefore, a less stable RecA/LexA complex has formed. 
Also, the effect of different ATP substrates (ATP, ATP-γ-S, or AMP-PNP) on the 
coprotease activity of RecA was tested.  This assay will be useful for crystallization trials 
since the lifetime for a crystal structure is expected to be 3 months with AMP-PNP, as 
opposed to 3 days with ATP-γ-S, or 4 hours with ATP (Wu et al., 2004).  Thus, the 
second objective for this assay is to find a stable RecA/LexA complex that can utilize 
AMP-PNP in the absence of ssDNA or high salt concentrations during the crystallization 
 
*The two LexA mutants do not undergo RecA-mediated cleavage since they are both defective in self-
cleavage mechanism. 
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trials, since high salt concentrations will impair the binding of ssDNA (Weinstock et al., 
1981a) and excess ssDNA will impair the binding of the LexA protein (Rehrauer et al., 
1996). 
5.3.1. Wild-type RecA Analysis 
In the ATPase assay, the ATPase activity for wild-type RecA was found to 
increase by 15-fold as salt concentrations reached 0.4 M and 0.8 M in the presence of 
∆69LexA K156A and in the absence of ∆69LexA K156A respectively (Figure 5.5).  Under 
these conditions, the maximum turnover rate (kcat, the number of ATP molecules 
hydrolyzed per RecA molecule per unit time) for RecA’s ATPase activity was 8 min-1, 
which was much lower than the reported values of 15-30 min-1 (Pugh and Cox, 1988).  
The differences in the turnover values were related to whether ADP was allowed to 
accumulate in the reaction, or regenerate into ATP by a coupling system that contained 
pyruvate kinase (Pugh and Cox, 1988).  Thus, the lower turnover rate reported in this 
study was caused by the accumulation of ADP in the reaction mixture, which inhibits 
RecA’s coprotease and ATPase activity (Moreau and Carlier, 1989; Weinstock et al., 
1981a).  (This was also true for the two RecA mutants examined in the following 
subheadings, since a coupling system was not used in the regeneration of ADP to ATP). 
Also, a lower salt concentration was able to stimulate RecA’s ATPase activity in 
the presence of ∆69LexA K156A when compared to RecA alone (Figure 5.5).  This result 
suggests that the LexA mutant was able to stimulate the ATPase activity of RecA that 
may otherwise be influenced by a higher salt concentration.  In the latter situation, 
complete stimulation of RecA’s activity by a high salt concentration was observed at 0.8 
M, where the two curves begin to overlap for RecA alone and RecA in the presence of 
∆69LexA K156A.  Thus, the salt concentrations in the range of 0.4-0.8 M were optimal in 
promoting RecA’s binding affinity for the LexA protein.  On the other hand, salt 
concentrations above 0.8 M should be avoided, since the electrostatic-shielding effect 
may disrupt RecA’s binding affinity for the LexA protein.  In the presence of C-terminal 
His-tagged LexA S119A (LexA S119A), increasing salt concentrations did not improve 
the ATPase activity of RecA when compared to RecA alone (Figure 5.5).  This may 
suggest that wild-type RecA had a poor/no binding affinity for LexA S119A as salt 
concentrations were increased. 
RecA’s binding affinity towards either LexA K156A or S119A mutant (i.e. the 
inhibitor) was reexamined with the inhibition assay.  This assay correlates the level of 
inhibition for RecA’s coprotease activity (i.e. lack of wild-type LexA cleavage products) 
with its binding affinity towards the LexA mutant. 
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Figure 5.5.   NaCl stimulation of the ATPase activity of wild-type RecA. 
 
The effect of increasing the salt concentrations on the ATPase activity of 
wild-type RecA (10 µM) in the absence (▲) and presence of ∆69LexA 
K156A (●; 40 µM) or C-terminal His-tagged LexA S119A (■; 40 µM).  
The enzyme solutions contained 150 mM MES/NaOH pH 6.9, 15% (w/v) 
PEG 400, and 5 mM ATP; and were incubated for 30 min at 37°C.  The 
amount of Pi released in 30 min was detected with a Malachite Green 
reagent at 620 nm, and the mean ±S.D was determined from two 
independent experiments. 
In the inhibition assay, the two LexA mutants were able to decrease the amount of 
wild-type LexA cleavage products that was facilitated by RecA’s coprotease activity, 
where ∆69LexA K156A was a more effective inhibitor than LexA S119A (Figure 5.6).  
These results suggested that wild-type RecA had a greater binding affinity for ∆69LexA 
K156A than LexA S119A, which were consistent with previous inhibition studies (Lin 
and Little, 1989; Slilaty and Little, 1987).  Additionally, RecA’s binding affinity towards 
LexA S119A appeared to be greater in the inhibition assay than the ATPase assay 
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(compare Figure 5.6 and Figure 5.5 respectively).  These variations may be caused by a 
lack of salt used in the inhibition assay, or the differences in the energetic cost when 
stimulating RecA’s ATPase activity than inhibiting its coprotease activity.  In general, 
RecA had a greater binding affinity for ∆69LexA K156A than LexA S119A as salt 
concentrations were increased.  Therefore, ∆69LexA K156A was used in the subsequent 
ATPase assays. 
 
Figure 5.6. Inhibition of wild-type RecA’s coprotease activity. 
 
Inhibition of wild-type RecA (5 µM) mediated cleavage of His-tagged wild-type LexA 
(40 µM) by either ∆69LexA K156A (10 µM) or His-tagged LexA S119A (10 µM).  The 
enzyme solutions contained 150 mM HEPES/NaOH pH 7.5, 15% (w/v) PEG 400, and 
1.5 mM ATP-γ-S; and were incubated for 2 hr at 20°C.  The experiment for the Control 
or –Inhibitor was the same as above, except that it lacked both a LexA mutant and 
ATP-γ-S, or a LexA mutant respectively.  The reaction mixtures were resolved on a 
15% SDS-polyacrylamide gel, and stained with Coomassie Brilliant Blue.  RecA-
mediated cleavage of His-tagged wild-type LexA produced a N-terminal fragment 
(histag-LexA1-84) and a C-terminal fragment (LexA85-202).  The last lane (right-hand 
side) contained Histag LexA S119A, in order to show the amount of sample loaded in 
the gel. 
In the coprotease assay for wild-type RecA, the protein was able to utilize ATP-γ-
S in the mediated-cleavage of wild-type LexA in the absence of dT36 oligonucleotides 
(Figure 5.7). On the other hand, in the presence of dT36 oligonucleotides, the protein was 
able to utilize all three ATP substrates (ATP, ATP-γ-S, and AMP-PNP) in the mediated-
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cleavage of wild-type LexA (Figure 5.7).  Thus, the RecA/LexA complex was not 
sufficiently stable enough to utilize AMP-PNP as a substrate in the absence of ssDNA.  
In general, the results for RecA’s ATPase and coprotease assays served as a guideline to 
determine whether the RecA mutants were hyper-active in their enzymatic activities. 
 
 
Figure 5.7.   ATP substrates and ssDNA stimulation of the coprotease
activity of wild-type RecA. 
The effect of different ATP substrates (1.5 mM) on wild-type RecA 
(10 µM) mediated cleavage of His-tagged wild-type LexA (40 µM).  
The enzyme solutions contained 150 mM HEPES/NaOH pH 7.5, 15% 
(w/v) PEG 400, and ±15 µM dT36 oligonucleotides; and were 
incubated for 1 hr at 20°C.  The control experiment was the same as 
above, except that the solution lacked an ATP substrate.  The reactions 
were resolved on a 15% SDS-polyacrylamide gel, and stained with 
Coomassie Brilliant Blue.  RecA-mediated cleavage of His-tagged 
wild-type LexA produced a N-terminal fragment (histag-LexA1-84) and 
a C-terminal fragment (LexA85-202). 
5.3.2. RecA K216E Analysis 
In the ATPase assay for RecA K216E, the turnover rate decreased by 42-fold in 
the range of 0.8 to 1.2 M salt when compared to wild-type RecA (compare Figure 5.8a 
and Figure 5.5 respectively).  As the salt concentrations increased, the ATPase activity of 
RecA K216E decreased in the presence or absence of ∆69LexA K156A (Figure 5.8a).  
This may suggest that the mutant was more sensitive to salt disruption when compared to 
wild-type levels.  Thus, high salt concentrations did not enhance the activity of RecA 
K216E, nor did it improve the mutant’s binding affinity for ∆69LexA K156A. 
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In the coprotease assay, RecA K216E was able to utilize ATP-γ-S in the 
mediated-cleavage of wild-type LexA in the absence of dT36 oligonucleotides.  On the 
other hand, in the presence of dT36 oligonucleotides, the mutant was able to utilize all 
three ATP substrates (ATP, ATP-γ-S, and AMP-PNP) in the mediated-cleavage of wild-
type LexA (Figure 5.8b), but its activity was lower than wild-type levels (Figure 5.7).  
These results suggest that the activity for RecA was not enhanced with the K216E 
mutation.  In general, the results indicate that RecA K216E was defective in its ATPase 
activity, and partially active in its coprotease activity.  Therefore, the K216E mutation did 
not enhance RecA’s binding affinity for the LexA protein when compared to wild-type 
levels. 
The E96D mutation was also introduced into RecA K216E by site-directed 
mutagenesis, since the double mutant (E96D K216E) was isolated from the yeast two-
hybrid screen and suspected of having hyper-activity (i.e. a potential candidate for 
enhancing the stability of the RecA/LexA complex).  In the coprotease assay, RecA 
E96D K216E was able to utilize ATP-γ-S in the mediated-cleavage of wild-type LexA in 
the absence of dT36 oligonucleotides (Figure 5.9).  On the other hand, in the presence of 
dT36 oligonucleotides, the double mutant was able to utilize all three ATP substrates 
(ATP, ATP-γ-S, and AMP-PNP) in the mediated-cleavage of wild-type LexA (Figure 
5.9).  Thus, the E96D mutation restores the defective coprotease activity of RecA K216E 
to wild-type levels (compare Figure 5.9 and Figure 5.7 respectively).  It is also 
noteworthy to point out that the ATPase activity was not examined for this double 
mutant.  The E96D mutation is known to reduce RecA’s rate of ATP hydrolysis by a 100-
fold (Campbell and Davis, 1999a), because the E96 residue acts as a general base for 
activating and positioning the water nucleophile for ATP hydrolysis (Wu et al., 2005). 
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Figure 5.8.   Stimulation of the ATPase and coprotease activity of RecA K216E. 
(a) The effect of increasing the salt concentrations on the ATPase activity of RecA 
K216E (10 µM) in the absence (▲) and presence (●) of ∆69LexA K156A (40 µM).  
The enzyme solutions contained 150 mM MES/NaOH pH 6.9, 15% (w/v) PEG 400, 
and 5 mM ATP; and were incubated for 30 min at 37°C.  The amount of Pi released in 
30 min was detected with a Malachite Green reagent at 620 nm, and the mean ±S.D 
was determined from two independent experiments.  (b) The effect of different ATP 
substrates (1.5 mM) on RecA K216E (10 µM) mediated cleavage of wild-type LexA 
(40 µM).  The enzyme solutions contained 150 mM HEPES/NaOH pH 7.5, 15% (w/v) 
PEG 400, and ±15 µM dT36 oligonucleotides; and were incubated for 1 hr at 20°C.  
The control experiment was the same as above, except that the solution lacked an 
ATP substrate.  The reaction mixtures were resolved on a 12% SDS-polyacrylamide 
gel, and stained with Coomassie Brilliant Blue.  RecA-mediated cleavage of wild-type 
LexA produced a N-terminal fragment (LexA1-84) that has run off the gel, and a C-
terminal fragment (LexA85-202) that is present at the bottom of the gel. 
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Figure 5.9.   ATP substrates and ssDNA stimulation of the coprotease 
activity of RecA E96D K216E. 
The effect of different ATP substrates (1.5 mM) on RecA E96D K216E 
(EDKE; 10 µM) mediated cleavage of His-tagged wild-type-LexA (40 µM).  
The enzyme solutions contained 150 mM HEPES/NaOH pH 7.5, 15% (w/v) 
PEG 400, and ±15 µM dT36 oligonucleotides; and were incubated for 1 hr at 
20°C.  The control experiment was the same as above, except that the 
solution lacked an ATP substrate.  The reaction mixtures were resolved on a 
15% SDS-polyacrylamide gel, and stained with Coomassie Brilliant Blue.  
RecA-mediated cleavage of His-tagged wild-type LexA produced a N-
terminal fragment (histag-LexA1-84) and a C-terminal fragment (LexA85-202). 
5.3.3. RecA K198N Analysis 
In the ATPase assay for RecA K198N, increasing salt concentrations did not 
improve the protein’s maximum turnover rate (6 min-1) when compared to wild-type 
RecA (compare Figure 5.10a and Figure 5.5 respectively), nor did it improve with the 
addition of ∆69LexA K156A when compared to wild-type RecA in the presence of 
∆69LexA K156A (compare Figure 5.10a and Figure 5.5 respectively).  Thus, the results 
indicate that the ATPase activity of RecA K198N was comparable to wild-type levels. 
In the coprotease assay for RecA K198N, the mutant was able to utilize ATP-γ-S 
in the mediated cleavage of wild-type LexA in the absence of dT36 oligonucleotides 
(Figure 5.10b).  In the presence of dT36 oligonucleotides, the mutant protein was able to  
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Figure 5.10.   Stimulation of the ATPase and coprotease activity of RecA K198N. 
(a) The effect of increasing the salt concentrations on the ATPase activity of 
RecA K198N (10 µM) in the absence (▲) and presence(●) of ∆69LexA K156A 
(40 µM).  The enzyme solutions contained 150 mM MES/NaOH pH 6.9, 15% 
(w/v) PEG 400 and 5 mM ATP; and were incubated at 37°C for 30 min.  The 
amount of Pi released in 30 min was detected with a Malachite Green reagent at 
620 nm, and the mean ±S.D was determined from two independent experiments.  
(b) The effect of different ATP substrates (1.5 mM) on RecA K198N (10 µM) 
mediated cleavage of His-tagged wild-type LexA (40 µM).  The enzyme solutions 
contained 150 mM HEPES/NaOH pH 7.5, 15% (w/v) PEG 400, and ±15 µM dT36 
oligonucleotides; and were incubated for 1 hr at 20°C.  The control experiment 
was the same as above, except that the solution lacked an ATP substrate.  The 
reaction mixtures were resolved on a 12% SDS-polyacrylamide gel, and stained 
with Coomassie Brilliant Blue.  RecA-mediated cleavage of His-tagged wild-type 
LexA produced a N-terminal (histag-LexA1-84) fragment that has run off the gel, 
and a C-terminal (LexA85-202) fragment that is present at the bottom of the gel. 
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utilize all three ATP substrates in the mediated cleavage of wild-type LexA (Figure 
5.10b).  The results indicate that the coprotease activity of RecA K198N was similar to 
wild-type levels (compare Figure 5.10 with Figure 5.7).  In general, the two assays 
indicate that the ATPase and coprotease activity of the K198N mutant was similar to 
wild-type levels.  Therefore, the K198N mutant did not improve RecA’s binding affinity 
for the LexA protein. 
5.4.  LexA Dimer Interface Mutants Characterization 
The dissociation constant for the LexA dimer (Kdimer) is in the picomolar range in 
vitro (Mohana-Borges et al., 2000).  This very low Kdimer value of 15 pM poses a problem 
when using standard techniques in detecting RecA’s binding preference for the monomer 
or dimer form of LexA.  To increase the Kdimer value of LexA, a single point mutation 
(either V100K, V100D, I196K, or I196D) was introduced at its dimer interface such that 
a charge-charge repulsion will disrupt the two interacting LexA monomers.  The K156A 
mutation was also introduced into the dimer interface mutants in order to (1) improve the 
stability of the samples in vitro, since the proteins are defective in self-cleavage; and (2) 
shift the conformation of LexA towards the cleavable form.  This study is related to the 
thermodynamic model for the formation of the RecA/LexA complex, since the stability 
of the RecA/LexA complex may be enhanced in the presence of the dimer interface 
mutants, as long as RecA has a greater binding affinity for the monomer form and not the 
dimer form of LexA. 
5.4.1. Size-exclusion Chromatography 
The purified LexA dimer interface mutants* were analyzed on a size-exclusion 
Protein-Pak 125 column, in order to determine if the mutants exist in the monomer or 
homodimer form.  Approximately 1 mg/ml of protein was loaded onto the column that 
was pre-equilibrated with 100 mM phosphate buffer pH 7.0, and resolved at a flow rate 
of 1 ml/min.  The control, ∆75LexA K156A was used as a marker for the homodimer 
form of LexA; this protein was found to elute at 8.53 min.  The two dimer interface 
mutants, ∆69LexA K156A V100D and ∆69LexA K156A V100K were found to elute 
between 8 to 9 min (Figure 5.11; a, b, and c respectively).  When the elution times for the 
 
* Samples were sent to Ron Geyer’s lab for size exclusion and mass spectrometry analysis. 
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two mutants were compared with the control, the results suggested that the two mutants 
existed in the homodimer form.  The other two mutants, ∆69LexA K156A I196D and 
∆69LexA K156A I196K were found to elute between 11 to 12 min (Figure 5.11; c and d 
respectively).  Since the elution time for these mutants proceeded after the homodimer 
peak, these results suggested that the two mutants existed in the monomer form.  The 
variation in elution times was attributed to the mass differences in each LexA mutant, 
since some of the proteins contained an optional hexahistidine tag (Table 5.2). 
Following size-exclusion chromatography, the mass of the monomer and 
homodimer peaks was then determined.  Each mutant (1 mg/ml) was resolved onto a 
reverse phase column (Symmetry 300 C4 3.5 µm) and then analyzed with a micromass 
liquid chromatography time of flight mass-spectrometer.  The mass for most of the 
samples agreed with the expected values listed in Table 5.2.  However, ∆69LexA K156A 
V100K and ∆69LexA K156A I196K were found to have an additional mass of ~20.5 Da.  
This may have been caused by the formation of a Na-adduct (21.98 Da), since NaCl was 
used by the mass-spectrometer during the ionization process.  Alternatively, this may 
have been caused by the oxidation of the tryptophan side chain residue to 
hydroxykynurenine (19.98 Da) (Berlett and Stadtman, 1997).  In general, the results 
indicated that ∆69LexA K156A I196D* and ∆69LexA K156A I196K existed as a 
monomer, while ∆69LexA K156A V100D and ∆69LexA K156A V100K existed as a 
homodimer. 
The two samples, 30 µM ∆69LexA K156A I196K (monomer) and 30 µM ∆75LexA 
K156A (dimer) were mixed together and tested for the formation of heterodimers.  The 
mixture was incubated for 1 hr at 4°C and then resolved on a size-exclusion column.  The 
mass of the mutants was then determined by mass-spectrometry as described above.  The 
size-exclusion chromatograms showed that the dimer peak eluted at 8.67 min, and the 
monomer peak eluted at 12.5 min (Figure 5.12a).  Upon analysis of the two peaks by 
mass-spectrometry, the dimer peak had only one molecular weight of 14.5 kDa (Figure 
5.12b), which corresponded to ∆75LexA K156A (Table 5.2).  The monomer peak also  
 
*No further analysis was conducted for ∆69LexA K156A I196D, since the yield of the sample was very low 
following purification. 
e.
d.
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a. c. 
Figur
(a) ∆
(d) ∆e 5.11.   Size-exclusion chromatograms for the LexA dimer interface mutants. 
75LexA K156A, (b) ∆69LexA K156A V100D, (c) ∆69LexA K156A V100K, 
69LexA K156A I196D, and (e) ∆69LexA K156A I196K.
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b. c.
Figure 5.12.   Size-exclusion chromatogram and MaxEnt spectra for a mixture
that contained equal ratios of ∆75LexA K156A and ∆69LexA K156A I196K. 
m/z (Da) m/z (Da) 
(a) Size exclusion chromatogram of the mixture that contained equal ratios of 
∆75LexA K156A (8.67 min) and ∆69LexA K156A I196K (12.50 min), and 
MaxEnt spectra for a mixture that contained equal ratios of (b) ∆75LexA 
K156A and (c) ∆69LexA K156A I196K. 
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had only one molecular weight of 15.1 kDa (Figure 5.12c), which corresponded to 
∆69LexA K156A I196K (Table 5.2).  Thus, there was a lack of heterodimer formation 
when ∆75LexA K156A and ∆69LexA K156A I196K were mixed together at equal ratios. 
Table 5.2.   Mass spectrometry results for the observed molecular 
masses, and the calculated molecular masses for the LexA mutants. 
Sample Comment MW (Da)  
  Calculated Observed 
∆75LexA K156A -Histag 14,465.20 14,464.96 
∆69LexA K156A -Histag 15,125.70 15,125.44 
V100D    
∆69LexA K156A +Histag 17,047.40 17,067.84 
V100K    
∆69LexA K156A +Histag, -Met 16,889.00 16,888.64 
I196D    
∆69LexA K156A +Histag 17,033.30 17,054.08 
I196K    
 -Histag 15,124.70 15,124.80 
5.4.2. Yeast One-hybrid Analysis 
In vivo, studies have shown that the dimer form of LexA has a 10-fold greater 
binding affinity for its DNA operator site than the monomer form of LexA1-88 (i.e. the 
individual DNA binding domain) (Bertrand-Burggraf et al., 1987; Brent and Ptashne, 
1985; Golemis and Brent, 1992).  Dimerization of the LexA repressor is believed to 
provide a favourable geometrical conformation for the DNA binding domain of LexA, 
such that the contacts with its operator site are optimized (Golemis and Brent, 1992); and 
also ensures that the two DNA strands do not melt (Silva and Silveira, 1993).  If the 
dimer interface mutants exist in the dimer form, they are expected to have a high DNA-
binding affinity as observed for the functional LexA repressor.  On the other hand, if the 
dimer interface mutants exist in the monomer form, they are expected to have a low 
DNA-binding affinity as observed for LexA1-88.  This rational was applied to the LexA 
dimer interface mutants, in order to determine whether the mutants exist in the monomer 
or dimer form by using the yeast one-hybrid system.  In other words, this system 
correlates the level of LexA’s binding affinity for its operator site with the type of species 
present (i.e. the monomer or dimer form). 
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Single point mutations at LexA’s dimer interface were introduced by site-directed 
mutagenesis by overlap extension PCR.  The b42 activation domain was also introduced 
at the C-terminal end of the LexA dimer interface mutants (Figure 5.13a).  This served as 
an indicator for the mutants’ binding affinity towards the lexA operator site.  The lexA 
mutants were cloned into the backbone of the pEG202 vector (Figure 5.13a) via 
homologous recombination in S. cerevisiae strain EY93.  The plasmid was then isolated 
from the S. cerevisiae strain EY93 cells and transformed into S. cerevisiae strain EY111, 
in order to test for their binding affinity towards the lexA operator site in vivo.  If the 
dimer interface mutants do not dimerize, they are expected to have a reduced DNA-
binding affinity, which is correlated to a reduced activation for the downstream reporter 
gene (Figure 5.13b).  If the dimer interface mutants are able to dimerize, they are 
expected to have a normal DNA-binding affinity, which is correlated to a normal level of 
activation for the down stream reporter gene (Figure 5.13c). 
The plasmid’s high copy number (2 µm origin) will allow the fusion protein to 
reach an estimated nuclear concentration of 4.5 to 9.0 µM (Golemis and Brent, 1992).*  
This establishes a physiological LexA concentration in the yeast cells that is slightly 
higher than the intracellular levels in E. coli, which is reported to fluctuate during its 
growth cycle between 0.7 to 5 µM (Dri and Moreau, 1993). 
In the yeast one-hybrid system, the mutants were tested for the activation of the 
lacZ reporter gene, which provides a blue-white colony assay on plates containing X-Gal.  
A blue phenotype suggests that LexA exists as a dimer (a strong binding affinity for its 
operator site), while a white phenotype suggests that LexA exists as a monomer (weak 
binding affinity for its operator site).  The mutants were also tested for the activation of 
the LEU2 gene, which allows the cells to grow on synthetic media that is lacking Leu.  
The latter assay is less stringent than the lacZ reporter gene; therefore, it will detect a 
weaker binding affinity between the LexA dimer interface mutants and their lexA 
operator site (Estojak et al., 1995). 
 
* The value for the estimated nuclear concentration is given for the LexA Gal4 fusion protein. 
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Figure 5.13.   Schematic overview for the design of the LexA dimer 
interface mutants in the yeast one-hybrid system. 
 
(a) A linear drawing of the plasmid that contains the lexA dimer 
interface mutant (V100D, V100K, I198D, or I198K) gene.  Expression 
of the lexA gene was constitutively expressed with the ADH1 
promoter.  (b) The LexA dimer interface mutants that do not dimerize 
will have a low DNA-binding affinity, which leads to a low expression 
of the reporter gene.  (c) The LexA dimer interface mutants that 
dimerize will have an high DNA-binding affinity, which leads to a 
high expression of the reporter gene. 
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The cells expressing the lexA mutants were plated on both X-Gal SD H- and X-
Gal SD H- L- media for 3 days at 30°C.  The mutants were found to activate the lacZ 
reporter gene, which produced the following colour intensities: wild-type, V100D > 
V100K, I196K > I196D (Figure 5.14).  Based on these colour intensities, the I196D 
mutation was more effective in destabilizing LexA’s DNA binding affinity, but it may 
not prove that LexA I196D exists more frequently in the monomer form.  In general, the 
point mutations V100D, V100K, and I196K did not significantly reduced LexA’s DNA 
binding affinity when compared to the control.  All of the mutants were found to activate 
the LEU2 reporter gene, which suggested that the dimer interface mutants were able to 
bind to their operator site (Figure 5.14).  More specifically, the results for the yeast one-
hybrid system might imply that the LexA mutants, I196K and I196D existed as dimers in 
vivo.  This was contrary to the size-exclusion results since the two mutants existed as 
monomers in vitro.  In either case, the I196D and I196K mutants were good candidates 
for determining whether RecA is able to bind to the monomer form of LexA in vitro. 
5.4.3. Inhibition Assay 
RecA’s binding preference for the monomer or dimer form of LexA was detected 
with the inhibition assay.  The level of inhibition for RecA’s coprotease activity (i.e. a 
lack of cleavage products for wild-type LexA) is correlated to its binding affinity for the 
LexA dimer interface mutants (inhibitor).  In this assay, there was a high amount of wild-
type LexA cleavage products generated in the presence of the dimer interface mutants 
when compared to ∆69LexA K156A (Figure 5.15).  These results suggested that RecA’s 
coprotease activity was not inhibited by the dimer interface mutants when compared to 
the positive inhibitory control, ∆69LexA K156A.  Thus, a lack of inhibition for RecA’s 
coprotease activity might suggest that the LexA dimer interface mutants acted as poor 
substrates for the binding of RecA. 
 
 
 
 
 
 
 
 
 
 
Yeast strains EY111 that contained the lexA b42AD plasmids were grown on 
both X-Gal SD H- and SD H- L- plates for 3 days at 30°C.  From top to bottom 
of the plate: negative control (wild-type LexA), wild-type LexA B42AD, and 
LexA B42AD dimer interface mutants (I196D, I196K, V100D, and V100K).  
Serial dilutions in the range of 10-1 to 10-4–fold were performed on each 
sample. 
Figure 5.14.   Yeast one-hybrid assay for the LexA dimer interface mutants. 
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Figure 5.15. Inhibition of RecA’s coprotease activity by the dimer 
interface mutants. 
Inhibition of wild-type RecA (5 µM) mediated cleavage of His-tagged 
wild-type LexA (40 µM) by either the ∆69LexA K156A dimer interface 
mutants (V100D, V100K, or I196K; 10 µM) or ∆69LexA K156A 
(K156A; 10 µM).  The enzyme solutions contained 150 mM 
HEPES/NaOH pH 7.5, 15% (w/v) PEG 400, and 1.5 mM ATP-γ-S; and 
were incubated for 2 hr at 20°C.  The experiment for –Inhibitor was the 
same as above, except that it lacked a LexA mutant.  The reaction 
mixtures were resolved on a 15% SDS-polyacrylamide gel and stained 
with Coomassie Brilliant Blue.  RecA-mediated cleavage of His-tagged 
wild-type LexA produced a N-terminal fragment (histag-LexA1-84) and a 
C-terminal fragment (LexA85-202). 
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6. DISCUSSION 
6.1. Enhancing the Stability of the RecA/LexA Complex 
The formation of the RecA/LexA complex is a thermodynamic process that can 
be broken up into three steps: (1) self-activation of RecA (active form), (2) a change in 
LexA’s conformation towards the cleavable form, and (3) the binding of the active form 
of RecA and the cleavable form of LexA.  Evidence for this model was provided by the 
enhanced stability of the RecA/LexA complex, which was achieved by reducing the 
energy barrier at each step.  For example, a volume excluding agent, PEG 400 was able 
to force the binding between the active form of RecA and the cleavable form of LexA 
(Figure 5.1 a and b); high concentrations of salt were able to promote the active form of 
RecA (Figure 5.5); and introducing the K156A mutation in LexA was able to promote the 
cleavable form of LexA (Figure 5.5 and Figure 5.6).  On the other hand, LexA S119A did 
not improve the stability of the RecA/LexA complex as salt concentrations were 
increased (Figure 5.5).  This result was also consistent with other inhibition assays, where 
LexA S119A had a weak inhibitory effect when compared to LexA K156A on the rate of 
RecA-mediated cleavage for the LexA repressor in vitro (Lin and Little, 1989; Slilaty and 
Little, 1987).  This is not surprising if it is hypothesized that RecA is able to bind to the 
cleavable form of LexA.  Thus, RecA may have a greater binding affinity for LexA 
K156A, because the energy barrier associated with the cleavable form of LexA is reduced 
(Luo et al., 2001), i.e. an input of free energy is not spent on the neutralization of the ε-
amino group of K156 since it is no longer a requirement with the K156A mutation, but it 
is spent on the burial of the K156A residue.  As for LexA S119A, RecA may have a 
weaker binding affinity for this mutant because the energy barrier associated with the 
cleavable form of LexA is not reduced, i.e. an input of free energy is spent on the burial 
and neutralization of the ε-amino group of K156 in LexA upon binding of the RecA 
protein (Luo et al., 2001).  The stability of the RecA/LexA complex was enhanced in the 
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presence of LexA K156A but not in the presence of LexA S119A (Figure 5.5 and Figure 
5.6). 
Given that an anion is believed to mimic the polyanionic phosphate backbone of 
DNA (Menetski et al., 1992; Pugh and Cox, 1988), high concentrations of anions may 
have a similar inhibitory effect as caused by either dsDNA or excess ssDNA on RecA’s 
binding affinity for the LexA repressor (Rehrauer et al., 1996; Takahashi and Schnarr, 
1989).  Thus, salt concentrations above 0.8 M should be avoided in facilitating stable 
RecA/LexA complexes (Figure 5.5) since the high ionic strengths may disrupt protein-
protein interactions due to its electrostatic shielding effect. 
6.1.1. Isolation of Hyper-active RecA Mutants 
In the yeast two-hybrid system, there were two possibilities why LexA K156A 
did not select for hyper-active RecA mutants that were able to enhance the stability of the 
RecA/LexA complex.  (1) A more stringent selection method was not used for the 
isolation of the hyper-active RecA mutants, such as the ADE2 and LEU2 reporter genes 
or LexA S119A.  However, this approach was time consuming since there was an 8-fold 
decrease in the number of positive interactions with LexA S119A when compared to 
LexA K156A.  (The same situation is expected when using the ADE2 reporter gene as 
opposed to the lacZ reporter gene, since both genes are stringent reporter genes).  (2) 
Screening for hyper-active RecA mutants may be biased towards external factors that 
bring about its activation.  For example, hyper-coprotease activity has been observed for 
RecA mutants that have lost their substrate specificity, such that the mutants are able to 
utilize other nucleotides or RNA molecules as substrates (Campbell and Davis, 1999a, 
1999b; Konola et al., 1995).  This is indeed the case for the RecA mutants, E96D, 
K198N, and K216I, since previous studies have shown that all of these mutants exhibit 
hyper-coprotease activity in vivo (Campbell and Davis, 1999a; McGrew and Knight, 
2003).  Therefore, the mutants may not influence the self-activation of RecA directly, but 
increase the number of substrates that are able to bring about its activation. 
Mutations at the K198 position of RecA were found to slightly reduce RecA’s 
coprotease and recombinase activity during UV-induced DNA damage in vivo (Hörtnagel 
et al., 1999; Larminat et al., 1992).  These studies are also consistent with the results 
presented in this thesis for the K198N mutation.  The mutant had a slightly reduced 
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ATPase activity (Figure 5.10a) and a normal coprotease activity (Figure 5.10b) when 
compared to wild-type levels in vitro (Figure 5.5 and Figure 5.7 respectively).  The slight 
reduction in the mutant’s activity may have been caused by the disruption in its L2 loop 
region, which is implicated in anion/DNA binding (Pugh and Cox, 1988; Story et al., 
1992).  Alternatively, the K198N mutation may affect RecA’s structure, which in turn 
impairs the binding of the anions.  In either case, the K198N mutation leads to a partial 
activation of RecA and in turn reduces the stability of the RecA/LexA complex. 
The RecA K216E mutant had a defective ATPase activity (Figure 5.8a) and a 
reduced coprotease activity (Figure 5.8b) when compared to wild-type levels in vitro 
(Figure 5.5 and Figure 5.7).  This mutation may have impaired the conformational 
changes that are induced upon ATP binding, since it is situated at the helix G region 
(ATPase core).  This idea is supported by: the changes in position of the helix G/L2 
region when comparing the RecA-dimer model (Wu et al., 2004) with the RecA filament 
model (VanLoock et al., 2003b); the close proximity of the K216 residue to the 
triphosphate of ATP in the RecA filament model (VanLoock et al., 2003b); and the 
limited extent to which RecA K216E is able to form ATP-induced polymers in vivo 
(Logan et al., 1997).  Thus, the mutation may impair some of the ATP-induced allosteric 
changes that are required for RecA’s strand exchange activities, but these additional 
changes may not be an absolute requirement for its coprotease activity.  This may explain 
why RecA K216E was found to be defective in its recombination activity for both UV-
damaged DNA repair and λ-phage recombination in vivo (Larminat et al., 1992; Skiba 
and Knight, 1994), while still functional in its coprotease activity in vitro. 
Interestingly, the E96D K216E double mutant was found to increase RecA’s 
coprotease activity (Figure 5.9) when compared to the K216E single mutant in vitro 
(Figure 5.8b).  This was expected since RecA E96D was found to have a 100-fold 
decrease in its ATP hydrolysis rate and an increase in its binding affinity for ATP, which 
in turn preactivates the RecA filament (Campbell and Davis, 1999a, 1999b).  Thus, a 
hyper-active RecA mutant such as the E96D mutation will enhance the stability of the 
RecA/LexA complex because the mutation will shift RecA’s conformation towards the 
active form. 
 80
The binding of anions to RecA’s primary ssDNA binding site is believed to 
stimulate its ATPase activity (Pugh and Cox, 1988).  However, salt did not stimulate the 
ATPase activity of RecA K216E (Figure 5.8a).  It is tempting to speculate that the lack of 
ATPase stimulation by salt is somehow associated with the loss of its ssDNA-binding 
sites by the K216E mutation.  However, the coprotease assay suggests that RecA K216E 
is still capable of binding to ssDNA at very low salt concentrations (Figure 5.8b); 
therefore, the mutant is expected to bind to other polyanions.  It is quite possible that 
RecA K216E may be more sensitive to preferential hydration, thereby making the active 
form of RecA less stable since it is disrupted by low ion concentrations.  In general, the 
hyper-coprotease activity of RecA K216E or RecA E69D K216E is not sufficient to 
stabilize the RecA/LexA complex such that AMP-PNP can be used as a substrate during 
crystallization trials. 
6.1.2. Significance of the Thermodynamic Model 
The crystal structure for the inactive form of EcRecA was solved 14 years ago 
(Story et al., 1992).  Since then there has been no crystal structures reported for either the 
active form of RecA or the RecA/LexA complex.  The thermodynamic model that is 
proposed in this thesis will hopefully overcome past failures during crystallization trials, 
and lead to a structural insight into the RecA/LexA complex.  This complex is important 
in understanding a similar RecA/CI-phage repressor (a LexA homolog) complex that has 
been implicated in the epidemiology of STEC diseases.  Therefore, a structural insight 
into the RecA/LexA complex will be useful in developing drugs that target the RecA/CI 
phage repressor complex, since there are no conventional drugs to treat STEC infections. 
6.2. LexA Dimer Interface Mutants 
In a recent paper, the preferred substrate for RecA-mediated cleavage of 
bacteriophage 434 repressor (a LexA homolog) was found to be the dimer form and not 
the monomer form (Pawlowski and Koudelka, 2004).  Therefore, it is very likely that 
RecA will have a greater binding affinity for the dimer form of LexA.  Despite that 
RecA’s binding preference has been determined, the work presented here is still useful in 
understanding why RecA does not bind to the dimer interface mutants. 
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In this thesis, the charge-charge repulsion established at the dimer interface of 
LexA by either mutation, I196D or I196K was found to prevent the protein from forming 
homodimers in vitro (Figure 5.11; d and e respectively).  The charged interface at LexA 
I196K was also found to prevent the protein from forming heterodimers with LexA 
K156A at equal ratios (Figure 5.12).  On the other hand, in vivo, the mutants, I196K, 
I196D, V100K and V100D might exist as dimers (Figure 5.14).  The former and latter 
results indicated that both mutants, I196K and I196D existed in the monomer form in 
vitro and in the dimer form in vivo respectively.  The lexA operator site in the yeast one-
hybrid system may be responsible for the dimerization of these mutants in vivo, since the 
DNA binding site has been reported to reduce the Kdimer value of LexA by 750-fold in 
vitro (Mohana-Borges et al., 2000).  Alternatively, the monomer form of LexA I196K or 
I196D may have a similar binding affinity for its lexA operator site as observed for the 
functional LexA repressor (dimer form) due to their intracellular concentrations.  This 
idea is based on the equation for the monomer repression of the uvrA gene (Bertrand-
Burggraf et al., 1987), which indicates that ~2 µM LexA1-88 is required to occupy 98% of 
the uvrA operator site.  Thus, LexA I196K or I196D is expected to have a similar DNA-
binding affinity as LexA1-88, because they are unable to dimerize in vitro.  It is quite 
possible that the mutant will reach a concentration of 2 µM in the yeast one-hybrid 
system, since the estimated nuclear concentration of a fusion protein is expected to be in 
the range of 4.5 to 9.0 µM (Golemis and Brent, 1992).  In general, it is very difficult to 
determine if the dimer interface mutants were able to prevent dimerization in vivo.  The 
high intracellular concentration of either LexA species may be able to overcome its weak 
binding affinity for its lexA operator site, and its lexA operator site is known to improve 
the dimerization of LexA. 
Finally, the dimer interface mutants were found to act as poor substrates for the 
RecA protein in vitro, since they failed to inhibit RecA’s coprotease activity (Figure 
5.15).  Either the V100D or the V100K mutation (dimer form) may have disrupted the 
overall conformation of the LexA dimer, which may have impaired RecA’s binding 
affinity for the LexA mutant and in turn decrease the stability of the RecA/LexA 
complex.  The I196K mutation (monomer form) may have disrupted LexA’s tertiary 
structure, since its hydrophobic dimer interface surface is exposed to the aqueous 
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environment as observed in a free energy study on the stability of phage repressors (LexA 
homologs) (Foguel and Silva, 1994; Rupert et al., 2000).  This may also explain why 
RecA does not bind to the monomer form of LexA I196K nor does it lead to a stable 
RecA/LexA complex.  In general, it is difficult to say whether RecA’s poor binding 
affinity for the LexA dimer interface mutants was the result of changes in LexA’s overall 
structure or a lack of dimerization in vitro. 
In conclusion, a LexA monomer was generated in vitro by introducing either the 
I196K or I196D mutation at LexA’s dimerization interface.  These mutants will be 
extremely useful in future crystallization trials and free energy studies in order to 
understand the proteins’ stability in solution and affinity for their operator site.  More 
importantly, understanding the stability of the dimer interface mutants in solution may 
influence the energy barrier that is associated at each step in the formation of the 
RecA/LexA complex. 
 83
7. REFERENCES 
Aihara, H., Ito, Y., Kurumizaka, H., Terada, T., Yokoyama, S., and Shibata, T. (1997). 
An interaction between a specified surface of the C-terminal domain of RecA protein and 
double-stranded DNA for homologous pairing. J. Mol. Biol. 274, 213-221. 
Aihara, H., Ito, Y., Kurumizaka, H., Yokoyama, S., and Shibata, T. (1999). The N-
terminal domain of the human Rad51 protein binds DNA: structure and a DNA binding 
surface as revealed by NMR. J. Mol. Biol. 290, 495-504. 
Battista, J. R., Ohta, T., Nohmi, T., Sun, W., and Walker, G. C. (1990). Dominant 
negative umuD mutations decreasing RecA-mediated cleavage suggest roles for intact 
UmuD in modulation of SOS mutagenesis. Proc. Natl. Acad. Sci. U.S.A. 87, 7190-7194. 
Berlett, B. S., and Stadtman, E. R. (1997). Protein oxidation in aging, disease, and 
oxidative stress. J. Biol. Chem. 272, 20313-20316. 
Bertrand-Burggraf, E., Hurstel, S., Daune, M., and Schnarr, M. (1987). Promoter 
properties and negative regulation of the uvrA gene by the LexA repressor and its amino-
terminal DNA binding domain. J. Mol. Biol. 193, 293-302. 
Bianco, P. R., and Kowalczykowski, S. C. (2001). RecA protein (London, Nature 
Publishing Group). 
Bianco, P. R., T.Tracy, R., and Kowalczykowski, S. C. (1998). DNA strand exchange 
proteins: A biochemical and physical comparison. Front. Biosci. 3, 570-603. 
Brenner, S. L., Zlotnick, A., and Griffith, J. D. (1988). RecA protein self-assembly. 
Multiple discrete aggregation states. J. Mol. Biol. 204, 959-972. 
Brent, R., and Ptashne, M. (1985). A Eukaryotic transcriptional activator bearing the 
DNA specificity of a Prokaryotic repressor. Cell 43, 729-736. 
Burckhardt, S. E., Woodgate, R., Scheuermann, R. H., and Echols, H. (1988). UmuD 
mutagenesis protein of Escherichia coli: overproduction, purification, and cleavage by 
RecA. Proc. Natl. Acad. Sci. U.S.A. 85, 1811-1815. 
Campbell, M. J., and Davis, R. W. (1999a). On the in vivo function of the RecA ATPase. 
J. Mol. Biol. 286, 437-445. 
Campbell, M. J., and Davis, R. W. (1999b). Toxic mutations in the recA gene of E. coli 
prevent proper chromosome segregation. J. Mol. Biol. 286, 417-435. 
 84
Cazaux, C., Blanchet, J.-S., Dupuis, D., Villani, G., Defais, M., and Johnson, N. P. 
(1998). Investigation of the secondary DNA-binding site of the bacterial recombinase 
RecA. J. Biol. Chem. 273, 28799-28804. 
Clark, A. J., and Margulies, A. D. (1965). Isolation and characterization of 
recombination-deficient mutants of Escherichia coli K12. Proc. Natl. Acad. Sci. U.S.A. 
53, 451–459. 
Cleland, J. L., Lam, X., Kendrick, B., Yang, J., Yang, T.-H., Overcashier, D., Brooks, D., 
Hsu, C., and Carpenter, J. F. (2000). A specific molar ratio of stabilizer to protein is 
required for storage stability of a lyophilized monoclonal antibody. J. Pharm. Sci. 90, 
310-321. 
Cotterill, S. M., Satterthwait, A. C., and Fersht, A. R. (1982). recA protein from 
Escherichia coli.  A very rapid and simple purification procedure: binding of adenosine 
5'-triphosphate and adenosine 5'-diphosphate by the homogeneous protein. Biochemistry 
21, 4332-4337. 
Courcelle, J., Khodursky, A., Peter, B., Brown, P. O., and Hanawalt, P. C. (2001). 
Comparative gene expression profiles following UV exposure in wild-type and SOS-
deficient Escherichia coli. Genetics 158, 41-64. 
Cox, J. M., Abbott, S. N., Chitteni-Pattu, S., Inman, R. B., and Cox, M. M. (2006). 
Complementation of one RecA protein point mutation by another. J. Biol. Chem. 281, 
12968-12975. 
Cox, M. M., and Lehman, I. R. (1981). Directionality and polarity in recA protein-
promoted branch migration. Proc. Natl. Acad. Sci. U.S.A. 78, 6018-6022. 
De Zutter, J. K., Forget, A. L., Logan, K. M., and Knight, K. L. (2001). Phe217 regulates 
the transfer of allosteric information across the subunit interface of the RecA protein 
filament. Structure 9, 47-55. 
DiCapua, E., Cuillel, M., Hewat, E., Schnarr, M., Timmins, P. A., and Ruigrok, R. W. 
(1992). Activation of recA protein. The open helix model for LexA cleavage. J. Mol. 
Biol. 226, 707-719. 
DiCapua, E., Ruigrok, R. W., and Timmins, P. A. (1990a). Activation of recA protein: 
the salt-induced structural transition. J. Struct. Biol. 104, 91-96. 
DiCapua, E., Schnarr, M., Ruigrok, R. W., Lindner, P., and Timmins, P. A. (1990b). 
Complexes of RecA protein in solution. A study by small angle neutron scattering. J. 
Mol. Biol. 214, 557-570. 
 85
Dong, Q., E.Blatter, E., W.Ebright, Y., Bister, K., and H.Ebright, R. (1994). 
Identification of amino acid-base contacts in the Myc-DNA complex by site-specific 
bromouracil mediated photocrosslinking. EMBO J. 13, 200-204. 
Dri, A.-M., and Moreau, P. L. (1993). Phosphate starvation and low temperature as well 
as ultraviolet irradiation transcriptionally induce the Escherichia coli LexA-controlled 
gene sfiA. Mol. Microbiol. 8, 697-706. 
Dutreix, M., Moreau, P. L., Bailone, A., Galibert, F., Battista, J. R., Walker, G. C., and 
Devoret, R. (1989). New recA mutations that dissociate the various RecA protein 
activities in Escherichia coli provide evidence for an additional role for RecA protein in 
UV mutagenesis. J. Bacteriol. 171, 2415-2423. 
Egelman, E. H. (2001). Does a stretched DNA structure dictate the helical geometry of 
RecA-like filaments? J. Mol. Biol. 309, 539-542. 
Eguchi, Y., Ogawa, T., and Ogawa, H. (1988). Cleavage of bacteriophage phi 80 CI 
repressor by RecA protein. J. Mol. Biol. 202, 565-573. 
Estojak, J., Brent, R., and Golemis, E. A. (1995). Correlation of two-hybrid affinity data 
with in vitro measurements. Mol. Cell. Biol. 15, 5820-5829. 
Foguel, D., and Silva, J. L. (1994). Cold denaturation of a repressor-operator complex: 
The role of entropy in protein-DNA recognition. Proc. Natl. Acad. Sci. U.S.A. 91, 8244-
8247. 
Friedberg, E. C., Walker, G. C., and Siede, W. (1995). DNA Repair and Mutagenesis 
(Washington, DC, American Society for Microbiology Press). 
Gardner, R. V., Voloshin, O. N., and Camerini-Otero, R. D. (1995). The identification of 
the single-stranded DNA-binding domain of the Escherichia coli RecA protein. Eur. J. 
Biochem. 233, 419-425. 
Geyer, C. R., and Brent, R. (2000). Selection of genetic agents from random peptide 
aptamer expression libraries. Meth. Enzymol. 328, 171-210. 
Golemis, E. A., and Brent, R. (1992). Fused protein domains inhibit DNA binding by 
LexA. Mol. Cell. Biol. 12, 3006-3014. 
Gonda, D. K., and Radding, C. M. (1986). The mechanism of the search for homology 
promoted by recA protein. J. Biol. Chem. 261, 13087-13096. 
 86
Gonzalez, M., Rasulova, R., Maurizi, M. R., and Woodgate, R. (2000). Subunit-specific 
degradation of the UmuD/D' heterodimer by the ClpXP protease: the role of trans 
recognition in UmuD' stability. EMBO J. 19, 5251-5258. 
Haque, R., Huston, C. D., Hughes, M., Houpt, E., and Petri, W. A. (2003). Amebiasis. N. 
Engl. J. Med. 348, 1565-1573. 
Harmon, F. G., Rehrauer, W. M., and Kowalczykowski, S. C. (1996). Interaction of 
Escherichia coli RecA protein with the LexA repressor. J. Biol. Chem. 39, 23874-23883. 
Heuser, J., and Griffith, J. (1989). Visualization of RecA protein and its complexes with 
DNA by quick-freeze/deep-etch electron microscopy. J. Mol. Biol. 210, 473-484. 
Honigberg, S. M., Gonda, D. K., Flory, J., and Radding, C. M. (1985). The pairing 
activity of stable nucleoprotein filaments made from recA protein, single-stranded DNA, 
and adenosine 5'-(γ-thio)triphosphate. J. Biol. Chem. 260, 11845-11851. 
Horrii, T., Ogawa, T., Nakatani, T., Hase, T., Matsubara, H., and Ogawa, H. (1981). 
Regulation of SOS functions: purification of E. coli LexA protein and determination of 
its specific site cleaved by the RecA protein. Cell 27, 515-522. 
Hörtnagel, K., Voloshin, O. N., Kinal, H. H., Ma, N., Schaffer-Judge, C., and Camerini-
Otero, R. D. (1999). Saturation mutagenesis of the E. coli RecA loop L2 homologous 
DNA pairing region reveals residues essential for recombination and recombinational 
repair. J. Mol. Biol. 286, 1097-1106. 
http://www.cdc.gov/epo/dphsi/casedef/hemolyticcurrent.htm (2005). Hemolytic Uremic 
Syndrome, post-diarrheal (Centers for Disease Control and Prevention). 
Karlin, S., and Brocchieri, L. (1996). Evolutionary conservation of RecA genes in 
relation to protein structure and function. J. Bacteriol. 178, 1881-1894. 
Kim, B., and Little, J. W. (1993). LexA and lambda CI repressors as enzymes: specific 
cleavage in an intermolecular reaction. Cell 73, 1165-1173. 
Kimmitt, P. T., Harwood, C. R., and Barer, M. R. (2000). Toxin gene expression by 
Shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS 
response. Emerging Infect. Dis. 6, 458-465. 
Konola, J. T., Nastri, H. G., Logan, K. M., and Knight, K. L. (1995). Mutations at Pro67 
in the RecA protein P-loop motif differentially modify coprotease function and separate 
coprotease from recombination activities. J. Biol. Chem. 270, 8411-8419. 
 87
Kowalczykowski, S. C. (1986). Interaction of RecA protein with a photoaffinity analogue 
of ATP, 8-Azido-ATP: determination of nucleotide cofactor binding parameters and of 
the relationship bwtweeen ATP binding and ATP hydrolysis. Biochemistry 25, 5872-
5881. 
Kowalczykowski, S. C. (1987a). Mechanistic aspects of the DNA strand exchange 
activity of E. coli recA protein. Trends Biochem. Sci. 12, 141-145. 
Kowalczykowski, S. C. (1987b). Mechanistic aspects of the DNA strand exchange 
activity of E. coli recA protein. Trends Biochem. Sci. 12, 141-146. 
Kowalczykowski, S. C. (1991). Biochemistry of genetic recombination: energetics and 
mechanism of DNA strand exchange. Annu. Rev. Biophys. Biophys. Chem. 20, 539-575. 
Kowalczykowski, S. C., Dixon, D. A., Eggleston, A. K., Lauder, S. D., and Rehrauer, W. 
M. (1994). Biochemistry of homologous recombination in Escherichia coli. Microbiol. 
Rev. 58, 401-465. 
Kowalczykowski, S. C., and Eggleston, A. K. (1994). Homologous pairing and DNA 
strand-exchange proteins. Annu. Rev. Biochem. 63, 991-1043. 
Kuzminov, A. (1999). Recombinational repair of DNA damage in Escherichia coli and 
Bacteriophage λ. Microbiol. Mol. Biol. Rev. 63, 751-813. 
Larminat, F., Cazaux, C., Germanier, M., and Defais, M. (1992). New mutations in and 
around the L2 disordered loop of the RecA protein modulate recombination and/or 
coprotease activity. J. Bacteriol. 174, 6264-6269. 
Lavery, P. E., and Kowalczykowski, S. C. (1992). Enhancement of recA protein-
promoted DNA strand exchange activity by volume-occupying agents. J. Biol. Chem. 
267, 9307-9314. 
Leahy, M. C., and Radding, C. M. (1986). Topography of the interaction of recA protein 
with single-stranded deoxyoligonucleotides. J. Biol. Chem. 261, 6954-6960. 
Leonard, N. J. (1984). Etheno-substituted nucleotides and coenzymes: fluorescence and 
biological activity. Crit. Rev. Biochem. Mol. Biol. 15, 125-199. 
Lin, L.-L., and Little, J. W. (1989). Autodigestion and RecA-dependent cleavage of Ind- 
mutant LexA proteins. J. Mol. Biol. 210, 439-452. 
Little, J. W. (1983). The SOS regulatory system: control of its state by the level of RecA 
protease. J. Mol. Biol. 167, 791-808. 
 88
Little, J. W. (1993). LexA cleavage and other self-processing reactions. J. Bacteriol. 175, 
4943-4950. 
Little, J. W., Edmiston, S. H., Pacelli, L. Z., and Mount, D. W. (1980). Cleavage of the 
Escherichia coli lexA protein by the recA protease. Proc. Natl. Acad. Sci. U.S.A. 77, 
3225-3229. 
Liu, Y., Stasiak, A. Z., Masson, J.-Y., McIlwraith, M. J., Stasiak, A., and West, S. C. 
(2004). Conformational changes modulate the activity of human RAD51 protein. J. Mol. 
Biol. 337, 817-827. 
Logan, K. M., Skiba, M. C., Eldin, S., and Knight, K. L. (1997). Mutant RecA proteins 
which form hexamer-sized oligomers. J. Mol. Biol. 266, 306-316. 
Luo, Y., Pfuetzner, R. A., Mosimann, S., Paetzel, M., Frey, E. A., Cherney, M., Kim, B., 
Little, J. W., and Strynadka, N. C. J. (2001). Crystal structure of LexA: A conformational 
switch for regulation of self-cleavage. Cell 106, 585-594. 
Malkov, V. A., and Camerini-Otero, D. R. (1995). Photocross-links between single-
stranded DNA and Escherichia coli RecA protein map to loops L1 (amino acid residues 
157–164) and L2 (amino acid residues 195–209). J. Biol. Chem. 270, 30230-30233. 
McGrew, D. A., and Knight, K. L. (2003). Molecular design and funcitonal organization 
of the RecA protein. Crit. Rev. Biochem. Mol. Biol. 38, 385-432. 
Menetski, J. P., Bear, D. G., and Kowalczykowski, S. C. (1990). Stable DNA 
heteroduplex formation catalyzed by the Escherichia coli RecA protein in the absence of 
ATP hydrolysis. Proc. Natl. Acad. Sci. U.S.A. 87, 21-25. 
Menetski, J. P., and Kowalczykowski, S. C. (1985). Interaction of recA protein with 
single-stranded DNA.  Quantitative aspects of binding affinity modulation by nucleotide 
cofactors. J. Mol. Biol. 181, 281-295. 
Menetski, J. P., and Kowalczykowski, S. C. (1987). Transfer of recA protein from one 
polynucleotide to another. J. Biol. Chem. 262, 2093-2100. 
Menetski, J. P., Varghese, A., and Kowalczykowski, S. C. (1988). Properties of the high-
affinity single-stranded DNA binding state of the Escherichia coli RecA protein. 
Biochemistry 27, 1205-1212. 
Menetski, J. P., Varghese, A., and Kowalczykowski, S. C. (1992). The physical and 
enzymatic properties of Escherichia coli recA protein display anion-specific inhibition. J. 
Biol. Chem. 267, 10400-10404. 
 89
Mikawa, T., Masui, R., and Kuramitsu, S. (1998). RecA protein has extremely high 
cooperativity for substrate in its ATPase activity. J. Biochem. 123, 450-457. 
Mirshad, J. K., and Kowalczykowski, S. C. (2003). Biochemical characterization of a 
mutant RecA protein altered in DNA-binding Loop 1. Biochemistry 42, 5945-5954. 
Mohana-Borges, R., Pacheco, A. B. F., Sousa, F. J. R., Foguel, D., Almeida, D. F., and 
Silva, J. L. (2000). LexA repressor forms stable dimers in solution. J. Biol. Chem. 275, 
4708-4712. 
Moreau, P. L., and Carlier, M.-F. (1989). RecA protein-promoted cleavage of LexA 
repressor in the presence of ADP and structural analogues of inorganic phosphate, the 
fluoride complexes of aluminum and beryllium. J. Biol. Chem. 264, 2302-2306. 
Morimatsu, K., Takahashi, M., and Nordén, B. (2002). Arrangement of RecA protein in 
its active filament determined by polarized-light spectroscopy. Proc. Natl. Acad. Sci. 
U.S.A. 99, 11688-11693. 
Nastri, H. G., Guzzo, A., Lange, C. S., Walker, G. C., and Knight, K. L. (1997). 
Mutational analysis of the RecA protein L1 region identifies this area as a probable part 
of the co-protease substrate binding site. Mol. Microbiol. 25, 967-978. 
Nguyen, T. T., Muench, K. A., and Bryant, F. R. (1993). Inactivation of the recA protein 
by mutation of histidine 97 or lysine 248 at the subunit interface. J. Biol. Chem. 268, 
3107-3113. 
Nohmi, T., Battista, J. R., Dodson, L. A., and Walker, G. C. (1988). RecA-mediated 
cleavage activates UmuD for mutagenesis: mechanistic relationship between 
transcriptional derepression and posttranslational activation. Proc. Natl. Acad. Sci. 
U.S.A. 85, 1816-1820. 
Ogawa, H., and Ogawa, T. (1986). General recombination: functions and structure of 
RecA protein. Adv. Biophys. 21, 135-148. 
Oppenheim, A. B., Kobiler, O., Stavans, J., Court, D. L., and Adhya, S. (2005). Switches 
in bacteriophage lambda development. Annu. Rev. Genet. 39, 409-429. 
Opperman, T., Murli, S., Smith, B. T., and Walker, G. C. (1999). A model for a umuDC-
dependent prokaryotic DNA damage checkpoint. Proc. Natl. Acad. Sci. U.S.A. 96, 9218-
9223. 
 90
Pattanayek, R., Wang, J., Mori, T., Xu, Y., Johnson, C. H., and Egli, M. (2004). 
Visualizing a circadian clock protein: crystal structure of KaiC and functional insights. 
Mol. Cell 15, 375-388. 
Pawlowski, D. R., and Koudelka, G. B. (2004). The preferred substrate for RecA-
mediated cleavage of bacteriophage 434 repressor is the DNA-bound dimer. J. Bacteriol. 
186, 1-7. 
Phizicky, E. M., and Roberts, J. W. (1981). Induction of SOS functions: regulation of 
proteolytic activity of E. coli RecA protein by interaction with DNA and nucleoside 
triphosphate. Cell 25, 259-267. 
Pugh, B. F., and Cox, M. M. (1988). High salt activation of recA protein ATPase in the 
absence of DNA. J. Biol. Chem. 263, 76-83. 
Quillardet, P., and Hofnung, M. (1993). The SOS chromotest: a review. Mutat. Res. 297, 
235-279. 
Rajagopalan, M., Lu, C., Woodgate, R., O'Donnell, M., Goodman, M. F., and Echols, H. 
(1992). Activity of the purified mutagenesis proteins UmuC, UmuD', and RecA in 
replicative bypass of an abasic DNA lesion by DNA polymerase III. Proc. Natl. Acad. 
Sci. U.S.A. 89, 10777-10781. 
Rehrauer, W. M., Lavery, P. E., Palmer, E. L., and Singh, R. N. (1996). Interaction of 
Escherichia coli RecA protein with LexA repressor. J. Biol. Chem. 271, 23865-23873. 
Reuven, N. B., Arad, G., Maor-Shoshani, A., and Livneh, Z. (1999). The mutagenesis 
protein UmuC is a DNA polymerase activated by UmuD', RecA, and SSB and is 
specialized for translesion replication. J. Biol. Chem. 274, 31763-31766. 
Riddles, P. W., and Lehman, I. R. (1985). The formaton of plectonemic joints by the 
recA protein of Escherichia coli.  Requirement for ATP hydrolysis. J. Biol. Chem. 260, 
170-173. 
Roberts, J. W., Roberts, C. W., and Craig, N. L. (1978). Escherichia coli recA gene 
product inactivates phage lambda repressor. Proc. Natl. Acad. Sci. U.S.A. 75, 4714-4718. 
Roland, K. L., Smith, M. H., Rupley, J., and Little, J. W. (1992). In vitro analysis of 
mutant LexA proteins with an increased rate of specific cleavage. J. Mol. Biol. 228, 395-
408. 
 91
Roman, L. J., and Kowalczykowski, S. C. (1986). Relationship of the physical and 
enzymatic properties of Escherichia coli RecA protein to its strand exchange activity. 
Biochemistry 25, 7375-7385. 
Rupert, P. B., Mollah, A. K. M. M., Mossing, M. C., and Matthews, B. W. (2000). The 
structural basis for enhanced stability and reduced DNA binding seen in engineered 
second-generation Cro monomers and dimers. J. Mol. Biol. 296, 1079-1090. 
Sambrook, J., and Russell, D. W. (2001a). Protocol 1: Two-hybrid and other two-
component systems. In Molecular cloning: a laboratory manual (New York, Cold Spring 
Harbor Laboratory Press), pp. 18.16-18.47. 
Sambrook, J., and Russell, D. W. (2001b). Protocol 6: Site-specific mutagenesis by 
overlap extension. In Molecular cloning: a laboratory manual (New York, Cold Spring 
Harbor Laboratory Press), pp. 13.36-13.39. 
Sauer, R. T., Ross, M. J., and Ptashne, M. (1982). Cleavage of the λ and P22 repressors 
by recA protein. J. Biol. Chem. 257, 4458-4462. 
Schiestl, R. H., and Gietz, R. D. (1989). High efficiency transformation of intact yeast 
cells using single stranded nucleic acid as a carrier. Curr. Genet. 16, 339-346. 
Schuller, S., Frankel, G., and Phillips, A. D. (2005). New insights into the role of Shiga 
toxins in intestinal disease. Gastroenterology 129, 4-5. 
Selmane, T., Wittung-Stafshede, P., Maraboeuf, F., Voloshin, O. N., Nordeèn, B., 
Camerini-Otero, D. R., and Takahashi, M. (1999). The L2 loop peptide of RecA stiffens 
and restricts base motions of single-stranded DNA similar to the intact protein. FEBS 
Lett. 446, 30-34. 
Serebriiskii, I. G., Golemis, E. A., and Uetz, P. (2005). The Proteomics Handbook 
(Totowa (NJ), Humana Press). 
Shin, D. S., Pellegrini, L., Daniels, D. S., Yelent, B., Craig, L., Bates, D., Yu, D. S., 
Shivji, M. K., Hitomi, C., Arvai, A. S., Volkmann, N., Tsuruta, H., Blundell, T. L., 
Venkitaraman, A. R., and Tainer, J. A. (2003). Full-length archaeal Rad51 structure and 
mutants: mechanisms for RAD51 assembly and control by BRCA2. EMBO J. 22, 4566-
4576. 
Shinagawa, H., Iwasaki, H., Kato, T., and Nakata, A. (1988). RecA protein-dependent 
cleavage of UmuD protein and SOS mutagenesis. Proc. Natl. Acad. Sci. U.S.A. 85, 1806-
1810. 
 92
Silva, J. L., and Silveira, C. F. (1993). Energy coupling between DNA binding and 
subunit association is responsible for the specificity of DNA-Arc interaction. Protein Sci. 
2, 945-950. 
Silver, M. S., and Fersht, A. R. (1982). Direct observation of complexes formed between 
recA protein and a fluorescent single-stranded deoxyribonucleic acid derivative. 
Biochemistry 21, 6066-6072. 
Silver, M. S., and Fersht, A. R. (1983). Inverstigation of binding between recA protein 
and single-stranded ploynucleotides with the aid of a fluorescent deoxyribonucleic acid 
derivative. Biochemistry 22, 2860-2866. 
Skiba, M. C., and Knight, K. L. (1994). Functionally important residues at a subunit 
interface site in the RecA protein from Escherichia coli. J. Biol. Chem. 269, 3823-3828. 
Skiba, M. C., Logan, K. M., and Knight, K. L. (1999). Intersubunit proximity of residues 
in the RecA protein as shown by engineered disulfide cross-links. Biochemistry 38, 
11933-11941. 
Slilaty, S. N., and Little, J. W. (1987). Lysine-156 and serine-119 are required for LexA 
repressor cleavage: a possible mechanism. Proc. Natl. Acad. Sci. U.S.A. 84, 3987-3991. 
Slilaty, S. N., and Vu, H. K. (1991). The role of electrostatic interactions in the 
mechanism of peptide bond hydrolysis by a Ser-Lys catalytic dyad. Protein Eng. Des. 
Sel. 4, 919-922. 
Story, R. M., Weber, I. T., and Steitz, T. A. (1992). The structure of the Escherichia coli 
RecA protein monomer and polymer. Nature 355, 318-325. 
Takahashi, M., Maraboeuf, F., and Nordén, B. (1996). Locations of functional domains in 
the RecA protein overlap of domains and regulation of activities. Eur. J. Biochem. 242, 
20-28. 
Takahashi, M., and Schnarr, M. (1989). Investigation of RecA-polynucleotide 
interactions from the measurement of LexA repressor cleavage kinetics. Eur. J. Biochem. 
183, 617-622. 
Tang, M., Pham, P., Shen, X., Taylor, J. S., O'Donnell, M., Woodgate, R., and Goodman, 
M. F. (2000). Roles of E. coli DNA polymerases IV and V in lesion-targeted and 
untargeted SOS mutagenesis. Nature 404, 1014-1018. 
 93
Tang, M., Shen, X., Frank, E. G., O'Donnell, M., and Woodgate, R. (1999). UmuD'2C is 
an error-prone DNA polymerase, Escherichia coli pol V. Proc. Natl. Acad. Sci. U.S.A. 
96, 8919-8924. 
Tateishi, S., Horii, T., Ogawa, T., and Ogawa, H. (1992). C-terminal truncated 
Escherichia coli RecA protein RecA5327 has enhanced binding affinities to single- and 
double-stranded DNAs. J. Mol. Biol. 223, 115-129. 
Tombline, G., Heinen, C. D., Shim, K.-S., and FishelDagger, R. (1990). Biochemical 
characterization of the human RAD51 protein. J. Biol. Chem. 277, 14434-14442. 
VanLoock, M. S., Yu, X., Yang, S., Galkin, V. E., Huang, H., Rajan, S. S., Anderson, W. 
F., Stohl, E. A., Seifert, H. S., and Egelman, E. H. (2003a). Complexes of RecA with 
LexA and RecX differentiate between active and inactive RecA nucleoprotein filaments. 
J. Mol. Biol. 333, 345-354. 
VanLoock, M. S., Yu, X., Yang, S., Lai, A. L., Low, C., Campbell, M. J., and Egelman, 
E. H. (2003b). ATP-mediated conformational changes in the RecA filament. Structure 11, 
187-196. 
Vershon, A. K., Liao, S.-M., McClure, W. R., and Sauer, R. T. (1987). Interaction of the 
bacteriophage P22 Arc repressor with operator DNA. J. Mol. Biol. 195, 323-331. 
Voloshin, O. N., Wang, L., and Camerini-Otero, R. D. (1996). Homologous DNA pairing 
promoted by a 20-amino acid peptide derived from RecA. Science 272, 868-872. 
Walker, G. C. (1985). Inducible DNA repair systems. Annu. Rev. Biochem. 54, 425-457. 
Wang, W.-B., and Tessman, E. S. (1986). Location of functional regions of the 
Escherichia coli RecA protein by DNA sequence analysis of RecA protease constitutive 
mutants. J. Bacteriol. 168, 901-910. 
Weinstock, G. M., McEntee, K., and Lehman, I. R. (1981a). Hydrolysis of nucleoside 
triphosphates catalyzed by the recA protein of Escherichia coli.  Characterization of ATP 
hydrolysis. J. Biol. Chem. 256, 8829-8834. 
Weinstock, G. M., McEntee, K., and Lehman, I. R. (1981b). Hydrolysis of nucleoside 
triphosphates catalyzed by the recA protein of Escherichia coli.  Steady state kinetic 
analysis of ATP hydrolysis. J. Biol. Chem. 256, 8845-8849. 
Weisemann, J. M., and Weinstock, G. M. (1988). Mutations at the cysteine codons of the 
recA gene of Escherichia coli. DNA 7, 389-398. 
 94
Witkin, E. M. (1991). RecA protein in the SOS response: milesontes and mysteries. 
Biochemie 1991, 133-141. 
Wong, C. S., Jelacic, S., Habeeb, R. L., Watkins, S. L., and Tarr, P. I. (2000). The risk of 
hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 
infections. N. Engl. J. Med. 342, 1930-1936. 
Wu, Y., He, Y., Moya, I. A., Qian, X., and Luo, Y. (2004). Crystal structure of archaeal 
recombinase RadA: A snapshot of its extended conformation. Mol. Cell 15, 423-435. 
Wu, Y., Qian, X., He, Y., Moya, I. A., and Luo, Y. (2005). Crystal structure of an 
ATPase-active form of Rad51 homolog from Methanococcus voltae. J. Biol. Chem. 280, 
722-728. 
Yu, X., and Egelman, E. H. (1992). Structural data suggest that the active and inactive 
forms of the RecA filament are not simply interconvertable. J. Mol. Biol. 227, 334-346. 
Yu, X., and Egelman, E. H. (1993). The LexA repressor binds within the deep helical 
groove of the activated RecA filament. J. Mol. Biol. 231, 29-40. 
Yu, X., Jacobs, S. A., West, S. C., Ogawa, T., and Egelman, E. H. (2001). Domain 
structure and dynamics in the helical filaments formed by RecA and Rad51 on DNA. 
Proc. Natl. Acad. Sci. U.S.A. 98, 8419-8424. 
Zimmerman, S. B., and Minton, A. P. (1993). Macromolecular crowding: biochemical, 
biophysical, and physiological consequences. Annu. Rev. Biophys. Biomol. Struct. 22, 
27-65. 
 
 
